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Abstract 
Carcinogenicity bioassay are among the best instruments to strengthen the 
evidence on which regulatory agencies vase their decision to classify harmful 
agents as human carcinogens, so they are fundamental to protect public health. 
The statistical analysis is fundamental to validate the results from carcinogenicity 
bioassay. This work aims to propose and illustrate some methodologies for the 
analysis of non-cancer outcomes, in particular for the analysis of time-to-death 
and of longitudinal measurements of body weights. The data from an old 
experiment were used for this purpose: 4 experiments aimed at testing the 
carcinogenic potential of Coca-Cola on Sprague-Dawley rats of different ages 
(randomized males and females of 7, 30, 39, 55 weeks of age, and their non-
randomized offspring, observed since birth) were re-analysed.  
Survival analysis aimed to verify the influence of the treatment, controlling for 
possible differences due to sex, age at beginning of observation and age of the 
dams at pregnancy. It was performed using Cox proportional hazards models for 
the rats of second generation, and accelerated failure-times models for those of 
first generation; the use of frailty terms was evaluated (univariate gamma frailty to 
account for unobserved heterogeneity applied to data from breeders; shared 
gamma frailty at the litter level applied to data from offspring).  
The analysis of longitudinal body weights of the offspring was aimed at verifying 
the relevance of treatment, controlling for physiological differences due to sex and 
age of the dams at gestation. It was performed using linear and nonlinear mixed-
effects models to handle the hierarchical structure of the data. Linear models were 
fitted using log-transformation of time and polynomial terms of order 3; nonlinear 
models consisted of growth models, in particular the Berkey-Reed model, that is 
usually used to analyse human growth during infancy, was applied.  
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Chapter 1 Introduction  
Cancer is one of the leading causes of death worldwide, and despite the 
encouraging progress achieved during the last decades both in prevention and 
treatment of some types, it remains a major threat to public health. The burden of 
the disease is substantial and rising, due to increasing incidence rates, the growth 
and ageing of the population, and the spreading prevalence of risk factors like 
pollution, smoking, alcohol consumption, obesity and hypertension also in 
developing countries: these factors reverse the habit to see cancer as a problem 
regarding economically developed countries, and make it a global issue (Global 
Burden of Disease Cancer Collaboration, 2015). Given this framework, the 
importance of prevention is clear.  
If we think about prevention in terms of public health, one of the most 
important issues is to identify the human carcinogens and to regulate their use. 
Carcinogens are all the biologic or synthetic substances, composites, technologies, 
occupational exposures and even lifestyles that may have a carcinogenic potential. 
It is necessary to identify the hazard, that is the capability of causing neoplastic 
effects under some circumstances; to assess the risk, defined as the actual 
carcinogenic effect expected if exposed to a cancer hazard, and understand the 
mechanisms of action. 
Experimental and epidemiological studies are the best currently available 
instruments to test and verify these effects; in particular long term and life-span 
carcinogenicity bioassays are the main experimental tools when carcinogenicity is 
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under exam. They usually employ rodents, in particular female and male mice and 
rats, treated with one or more exposure concentration of the tested substance and 
compared with untreated controls; the main route of administration to choose 
between, according to the characteristic of the agent, are inhalation, dermal and 
the most common, oral. The observation usually begins around 7 weeks of age, 
when the subjects have ended the weaning period and are completely independent, 
and lasts 104 weeks, or for the whole life; if the human pattern of exposure 
requests so, perinatal exposures can be evaluated, to verify the effects during the 
critical developmental phases of gestation and lactation.  
The amount of information that a well-designed and well-conducted study can 
offer is impressive: their primary purpose is to characterise the carcinogenic 
properties of the agent,verifying if it might increase the age-specific incidence of 
malignant tumours, reduce its latency, intensify its severity or multiplicity (IARC, 
2006) or, less directly, trigger a harmful effect in another agent or act in a 
combined way with it; they can also establish the existence of a dose-response 
relationship, identify target organs, and help to set a benchmark dose or a no-
observed adverse effect level. Broad, strong and scientifically sound evidence is 
the base on which the organizations in charge (like the International Agency for 
Research on Cancer, the European Chemicals Agency, or the Environmental 
Protection Agency, the Food and Drugs Administration or the National 
Toxicologic Program for the United States) can classify dangerous agents as 
human carcinogens. The codification can in turn boost the action from regulatory 
agencies, that may decide to regulate or ban the use of these substances in order to 
protect and promote human health. 
Since the early 1980s most of the agencies involved in the classification and 
regulation of dangerous substances collected the most up-to-date and agreed-on 
options and procedures in experimental design, conduct of the study, reporting 
and analysis of the results, and formalized them into guidelines and regulations, 
that have been enriched and reviewed in the light of scientific progress, advance 
of procedures and consideration for the animal’s welfare (OECD, Test No. 451: 
Carcinogenicity Studies 2009). The main purposes are to grant and even out the 
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quality of the bioassays they base their knowledge on, and to assure the 
comparability of results. Even if today almost every agency has specific protocols, 
a common reference can be recognized in the guidelines drafted by the 
Environment, Health and Safety Program and the Working Group on Testing from 
the Organisation for Economic Cooperation and Development. Their Guidances 
for testing the chemicals and the related documents represent the most 
comprehensive collection of procedures, and among the very few to explicitly 
treat in detail and depth the statistical analysis of data (Hothorn 2014).  
Statistical analysis is universally recognised to be integral part of studies: an 
appropriate experimental design is the cornerstone to answer the research 
question, and statistical evaluation of the data is the necessary complement to 
establish and quantify whether the exposure to the selected agent is associated 
with adverse effects. Between the different “schools of thought”, the classical 
frequentist approach and the concept of hypothesis testing have been chosen to 
maintain coherence with most of the work done in toxicology. 
One of OECD’s guidelines (OECD 2012) is partly devoted to illustrate and 
explain in depth how to design and conduct the appropriate statistical tests based 
on the kind of experiment, its objective and the type of data; it also helps to 
interpret the results and to understand their real meaning and relative importance. 
The methods are systematically organized into a flowchart: according to the 
nature of the data, the appropriate “branch” of the tree is chosen, and omnibus 
tests to highlight overall differences between groups or tests for linear trend are 
suggested, preceded by several tests to verify the respect of their assumptions. In 
some cases when these are not met and it is possible to transform the data, a 
circular path is proposed and the tests repeated.  
What stands out is that consolidate and advanced methodologies exists and are 
routinely used for the analysis of tumor incidence, which is for the direct 
assessment of carcinogenicity. As it was previously highlighted, nevertheless, a 
good designed and performed study produces a great amount of additional 
information such as the body weights, food and beverages consumption, or the 
time of survival in life-span studies. Their importance to have a picture of the 
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health status of the animals involved and the good progress of the experiment is 
clear, but this potential at the moment is not fully exploited, since even the most 
detailed guideline proposes quite superficial analysis like those illustrated in the 
OECD flowchart.  
Today many statistical methodologies exist to treat data of this kind, and their 
application to carcinogenicity bioassays may allow to fully use all available 
information and to integrate them, to obtain a richer knowledge of the effects of 
the tested compound. The idea for this work started from the will to capitalise the 
potential of the dataapplying different methods to experimental studies, to verify 
if they can shed a new light on data and contribute to understand and establish the 
effect of the tested substances on health.  
The research was promoted by a local research centre needing help to perform 
routine statistical analysis and looking for ways to exploit the potetial coming 
from their experience in carcinogenicity studies. The Ramazzini Institute was 
founded as a social cooperative in 1987 but is active since the early ‘70s thanks to 
the work of Prof. Cesare Maltoni, who gathered the link between living and 
working environment and cancer, and performed life-span bioassays in the 
laboratories in Bentivoglio (Bo) to understand the mechanisms of action of the 
disease, and  identify and quantify on experimental base the toxic and carinogenic 
potential of widespread substances. During the decades dozens of experiments 
contributed to the identifications of many carcinogens. 
This work takes up an already published experiment again, the Coca-Cola 
experiment, that didn’t show ashtonishing results in carcinogenicity tout court, but 
could present some interesting features in other measures that were not analysed 
in depth at the time; in the following chapter the experimental design of this 
bioassay and its results, as were published, will be presented, together with a brief 
exploratory analysis. The third and the fourth chapters are dedicated to specific 
topics, and represent the core of the research: survival analysis and the analysis of 
longitudinal recordings of body weights, respectively. Each will start with a 
recognition of the literature, then present the data, the models and analysis that 
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were performed, and the results obtained. The research will end with a discussion 
of the work done, and some conclusion will be drawn. 
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Chapter 2 The Coca-Cola study 
Diet can become one of those life habits to ease the occurrence of cancer in 
different ways: some food components have the direct ability to induce the 
disease; some contain potentially dangerous additives to improve their stability, 
preservation or even just the appearance; or in general, the excessive caloric 
intake can lead to overweight and obesity, that has been identified as a risk factor 
for some types of cancer (Calle E.E. 2003) (RAPP 2005). Given the impossibility 
to study diet as a whole, experimental studies have been used to evaluate the 
impact of single nutrients or food components.  
Coca-Cola is a widespread product among the population of any age, socio-
economic status and country, its concentration of sugar and the caloric power are 
very high: for these reasons, the “Cesare Maltoni” Cancer Research Centre of the 
the Ramazzini Institute1 decided to evaluate its possible association with tumour 
incidence in rodents. Starting from 1986 several sub-studies were performed, each 
involving rats or different ages, males and females, randomized in two groups, the 
treated and the controls.  
 The design and the conduction of the bioassay will be now illustrated along 
with the results, as they were originally published. In order to have a clearer 
picture of the available data, the last part of the chapter will contain also a first 
exploratory analysis.  
                                                          
1 At the time named European Ramazzini Foundation 
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2.1 The experimental design2 
To verify the long-term influence of strong Coca-Cola consumption on the 
development of tumours, the bioassay planned it to be administered to Sprague-
Dawley rats as a substitute of drinking water for the whole life span, until 
spontaneous death of the animals.  
 
Treatment Age at start M F 
Coca-Cola 7 weeks 80 80 
Drinking water 7 weeks 100 100 
Coca-Cola 55 weeks 70 70 
Drinking water 55 weeks 70 70 
Coca-Cola Offspring (55) 28 24 
Drinking water Offspring (55) 32 24 
Coca-Cola 30 weeks 55 55 
Drinking water 30 weeks 55 55 
Coca-Cola Offspring (30) 74 73 
Drinking water Offspring (30) 110 98 
Coca-Cola 39 weeks 110 110 
Drinking water 39 weeks 110 110 
Coca-Cola Offspring (39) 67 65 
Drinking water Offspring (39) 49 55 
 
Table 1: Experimental plan of the four bioassays performed for the project 
 
The experimental plan is summarized above in Table 1: it wanted to account 
for possible differences in the metabolism and the mechanism of action linked to 
different ages, therefore four different experiments were conducted, involving 
respectively female and male breeder rats of 30, 39 and 55 weeks of age and all 
their offspring born in all litters, treated since prenatal life, and female and male 
non-breeding rats of 7 weeks of age. All animals were bred from the internally 
grown colony, formed at the beginning of the laboratories’ activity in the ‘70s.  
All breeders were identified, separated by sex and assigned to each 
experimental group, so that no more than one female and one male belonging to 
                                                          
2 All information and data in this and the following paragraph come from the original publication 
of Belpoggi F. et al. Specificata fonte non valida..  
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the same litter were in the same one; they were housed in groups of five in 
makrolon cages until scheduled time of mating and starting of the treatment, then 
placed in breeding cages for a week. Females were housed individually for the 
whole period of the pregnancy and the weaning, and then went back to the regular 
housing for the rest of the experiment; all pups from every litter after the weaning 
period were identified, separated by sex and assigned to the same treatment group 
as their breeders. Cages belonging to both treatments were kept in the same room, 
under the same living conditions and with the same diet. The treatment consisted 
in substituting drinking water with ad libitum Coca-Cola, that was supplied every 
2 weeks by an Italian retailer and was mechanically shaken before subministration 
to eliminate CO2, and it lasted until spontaneous death.  
During the observation, the animals were checked daily for physical and 
behavioural problems; the individual body weight and mean beverages and food 
consumption for cage were measured weakly for the first 13 weeks of 
observation, every 2 weeks until week 104, and every 8 weeks later, while 
complete examinations to check and report everything about the health status 
were performed weekly then every 2 weeks for the whole life.  
After death, complete necropsy was done on every subject, all pathological 
lesions and all organs and systems3 underwent histopathology, were preserved in 
70% ethyl alcohol (bones were fixed in 10% formalin and decalcified), trimmed 
and processed as paraffin blocks. 3-5 µm sections of every block were sliced and 
coloured with haematoxylin-eosin, and finally examined microscopically by a 
group of pathologists; a senior pathologist supervised and reviewed all tumours 
and lesions of neoplastic interest.  
The statistical analysis was performed on tumour incidences only using a χ2 
test to evaluate the significance of differences between treated and controls.  
                                                          
3Skin and subcutaneous tissue, the brain, pituitary gland, Zymbal glands, salivary glands, 
Harderian glands, cranium (with oral and nasal cavities and external and internal ear ducts, 5 
levels), tongue, thyroid and parathyroid, pharynx, larynx, thymus and mediastinal lymph nodes, 
trachea, lung and mainstem bronchi, heart, diaphragm, liver, spleen, pancreas, kidneys and adrenal 
glands, oesophagus, stomach (fore and glandular), intestine (4 levels), bladder, prostate, uterus, 
gonads, interscapular fat pad, subcutaneous and mesenteric lymph nodes, and any other organ or 
tissue with pathological lesions.  
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2.2 Results 
It was chosen to aggregate data from all breeders, and to consider all offspring 
together (animals who started treatment since embryonic life and the group 
observed since the age of 7 weeks).  
Fluid consumption differed markedly between treated and control animals, the 
former drinking twice the amount of the latter; conversely, food consumption was 
almost 40% minor among the Coca-Cola consumers. Body weight was higher 
both in breeders and offspring, for both sexes; no significant difference in survival 
was observed, just a slight decrease in female offspring.  
The following differences were observed in tumour occurrence:  
1. A slight increase in malignant tumour incidence;  
2. A statistically significant (P < 0.01) increase in malignant mammary 
tumours and total mammary tumours, both in breeders and offspring 
females;  
3. A statistically significant increase in adenomas of the exocrine component 
of pancreas in male (P < 0.01) and female (P < 0.05) breeders, and in male 
(P < 0.01) and female (P < 0.01) offspring; No exocrine carcinomas were 
observed.  
4. An increase in islet cell carcinomas was observed between female breeders 
and offspring; although it’s not statistically significant, it should be noted 
that looking at the historical controls, only one (0.04%) islet cell carcinoma 
out of 2274 untreated females was observed.  
They finished concluding that the significant rise in the occurrence of 
mammary gland tumours could confirm a correlation between higher body 
weight and increased risk of mammary cancer, and that the relatively high 
number of pancreatic islet cell carcinoma compared to the historical controls 
shall not be underestimated, even if not significant. Therefore, even if the 
human consumption is rarely as extreme as the one designed in the experiment, 
it was confirmed that an abuse of high caloric/ high sugar beverages like soft 
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drinks can ease overweight and obesity, that in turn is a risk factor for human 
health and cancer.  
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Chapter 3 The analysis of survival data  
When referring to “survival data” in carcinogenicity studies, the narrower 
interpretation is the correct one, since they literally indicate the time until death. 
In more common 2-years or chronic experiments, we find under this label the 
duration of life of the animals deceased before the official time of cessation, that 
will be those who experienced the “event of interest”, while the surviving ones 
will be treated as censored; in way less usual life-span studies the meaning is the 
same, except that there will be no censored observations, since the experiment 
lasts until the spontaneous death of the last animal.  
The duration of life is often under scrutiny in epidemiological studies and in 
clinical trials, but is rarely the outcome of primary interest in carcinogenicity 
bioassays, that are aimed to test the incidence of neoplastic lesions under different 
doses of treatment. Still, these data are collected and analysed in any kind of study 
since they allow to keep the general trend of the experiment under control during 
its execution, verifying that the tested compound has not such a high toxic 
potential to reduce too much the treated groups. The excessive decrease of sample 
size can threaten the sensitivity of the analysis, and increase the likelihood of 
obtaining false positives and false negatives (WHO 1987).  
When studying cancer these data acquire even more relevance for the nature of 
the phenomenon, since the probability of developing neoplastic lesions increases 
with age. Moreover, if the tested substance has the power to affect the survival for 
toxicity not related to tumour, statistical analysis of incidence may result biased: if 
the treatment reduces excessively the duration of life, it can underestimate the 
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carcinogenic potential; conversely, if it increases the longevity, the effect on 
cancer development may be overestimated (OECD 2012).  
These considerations led regulatory authorities and journals to request an 
evaluation of the differences in survival for every study to be considered, and to 
include indications about how to perform these analyses in the guidelines and the 
protocols.  
 
 
3.1 The analysis of time-to-event data according to the guidelines  
As it was mentioned in the introduction, guidelines drafted from the most 
authoritative national and international agencies have become an essential 
instrument for research centres, enhancing the possibility of producing quality 
research that can contribute to form the scientific base for the regulation of 
harmful agents. The documents (OECD 2012) (OECD 2009) from the Guidelines 
for testing the Chemicals Series drafted by Organization for Economic 
Cooperation and Development will again be the main reference here, since they 
are the most detailed and comprehensive in the identification of statistical 
procedures and methodologies.  
The first indication they give, is that the differences in survival need to be 
explored to guarantee the presence of a sufficient number of individuals to 
preserve the power of the tests to be performed, and to verify whether the analysis 
of incidence will have to be corrected. Survival data represent times, in this 
context usually days since the starting of the observation or weeks of age, and 
have some particular features: their distribution is not symmetric but tends to be 
positively skewed, and they are often censored - mostly right censored in the 
context of randomized bioassays. These peculiarities prevent the use of standard 
methods for continuous data.  
The suggested steps to identify differences or dose-response relationships in 
survival are totally based on non-parametric tests like the Mantel-Cox test, the 
generalized Wilcoxon or Kruskal-Wallis test, and the Tarone trend test. The 
preferred methodology to compare the duration of lives among the experimental 
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groups consists in estimating the survivor function using the product-limit 
method, proposed by Kaplan-Meier in 1958. It is based on the construction of a 
series of time intervals, such that each contains at least one event (that is assumed 
to occur independently from all others), and the event time is taken as beginning 
of the interval; the probability of survival is calculated for each interval as the 
ratio of subjects surviving and subjects at risk. The estimate is the product of the 
probabilities calculated on all time intervals, and it can be represented graphically 
as a step function, with the estimate probabilities remaining constant between 
adjacent death times, and decreasing at each event (Collett 2003). Different curves 
can be estimated for experimental groups, and differences are to be formally 
tested using the log-rank test.  
The non-parametric approach suggested in the guidelines is very appealing, 
given its simplicity and the possibility of representing the estimates graphically, 
that allows to catch many information about the data at a glance. This is useful, 
and may be sufficient in this kind of experiments, where the subjects under study 
are randomized and share every condition (type of caging, room, temperature, 
diet, number and scheduled timing of checking, …) except for treatment. In some 
situations, nevertheless, we might be interested in obtaining an estimate of the 
treatment’s effect on survival, or in the effect of other factors: here this univariate 
approach is a useful exploratory tool, but more sophisticated methods are 
necessary.  
Let’s take the Coca-Cola study as an example: the consumption of this 
compound is so widespread that we likely would not expect a strong, direct 
influence on survival. However, for its characteristic (highly sweetened, highly 
caloric) we may expect it to have an influence on body weight and mass 
composition, so that a heavy consumption like the one outlined in this experiment 
might ease overweight or even obesity on treated rats. These conditions may 
reasonably affect survival, but we are not able to account for and estimate their 
effect.  
Another feature of this experiments is that they involved adult rats and their 
offspring, to verify effects of perinatal exposure: all alive pups from all litters 
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were included, each in the same treatment regime as their breeders, so 
randomization was avoided in the second generation of exposed. This poses a 
problem of “familiarity”: individuals are more likely to share characteristics and 
propensity for diseases, so we expect to easily find similar paths among animals 
from the same litter.  
Finally, when plotting the Kaplan-Meier estimates of the survivor or the hazard 
functions, we may obtain crossing step functions: very close functions with 
similar paths might mean that relevant differences among groups do not exist, 
while non-parallel curves of the logarithm of the hazard functions might pose a 
doubt on the proportionality of the hazard. When there are reasons to question the 
assumption of proportional hazard, the Wilcoxon test might be more suitable than 
the log-rank test to assess differences among groups, but a modelling approach 
could be much more informative and appropriate.  
 
 
3.2 Other methods for survival analysis:  
3.2.1 The Proportional Hazard model  
To take advantage of all information and to give thorough answers to the 
research questions, we need to leave the hypothesis testing approach and choose 
the modelling approach.  
Survival data can be modelled to explore the risk of death at any time after the 
beginning of the study: the hazard function is the object of interest, representing 
the instantaneous probability of death at the time, given that the subject has 
survived until that time. The aim is to determine which conditions affect the form 
of the hazard function, and to obtain the estimate of the function itself for the 
individuals. The most commonly used multivariate approach is the proportional 
hazard model, proposed by Cox (1972), that has lately become quite popular also 
in carcinogenicity studies thanks to its flexibility and the diffusion of statistical 
packages of easy use. The Cox model is necessary for the use and understanding 
of many of the methodologies that will be proposed later, but is not the main topic 
of this section, so it will be just briefly introduced here.  
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The proportional hazard model explains the hazard of death at any time t as 
depending on the values x1, x2, …xp of p explanatory variables recorded at the 
time origin of the study, X1, X2, … Xp:  
ℎ𝑖(𝑡) = exp(𝜂𝑖) ℎ0(𝑡),        𝜂𝑖 = ∑ 𝛽𝑗𝑥𝑗𝑖
𝑝
𝑗=1  
where ℎ0(𝑡) is the baseline hazard function, representing the hazard at time t 
for a subject for whom all values of the covariates are 0, and𝜂𝑖 is the linear 
component of the model, containing the explanatory variables 𝑥𝑝and the 
respective coefficients 𝛽𝑝. The estimated effect can be interpreted in terms of 
hazard ratios (𝑒𝑥𝑝(𝛽𝑖) ): if greater than one, it indicates that the hazard of the 
event is positively associated with the corresponding covariate. This is one of the 
most important advantages of the modelling approach: it allows to consider the 
influence of several risk factors at one time. These are typically categorical, 
ordinal or continuous covariates, whose values is recorded at the beginning of the 
observation, but several expansions have been studied in time, so that a better 
representation of the phenomena under study could be reached.  
The essential features of this model are that the baseline hazard is estimated 
non-parametrically using the maximum likelihood method, so no assumption is 
made on the distribution of survival times (thus the model is defined semi-
parametric), and that its formulation assumes the proportionality of the hazards: 
since the covariates act multiplicatively on the hazard at any time, the hazard in 
any “group” is a constant multiple of the hazard in any other, and therefore the 
survival curves should never cross.  It is fundamental to assess the adequacy of 
the model: this includes to verify whether all and only the appropriate explanatory 
variables have been included in the model, and that the correct functional form 
has been used; to check for the presence and the nature of extreme values; and of 
course, to verify the assumption of proportional hazard. Visual inspection of the 
data is very useful, but must be supported by diagnostic of the residuals.  
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3.2.2 Accelerated failure-times models 
The analysis of graphical representation of the data and the diagnostic of the 
residuals are fundamental and should never be neglected, to assess the validity of 
the models built. One of the aspects that should always be evaluated is the 
tenability of the condition of proportionality of hazards, since it is one of the 
assumptions on which the Cox model and other parametric models for survival are 
based. Very often indeed real data do not behave this way: in these cases, 
alternatives are to be considered.  
Models that do not require hazard to remain constant are the accelerated failure 
time models: the basic idea is that the effect of covariates or risk factors is 
constant in time and multiplicative on the time scale (instead that on the hazard 
scale, as in PH models), accelerating or decelerating the event of interest.  
In the most generic specification, the survivor function can be written as 
𝑆(𝑡) = 𝑆0 (𝜑𝑡) 
where 𝑆0 (𝑡) is as usual the baseline hazard function, and 𝜑 represents the 
acceleration factor, dependent on the covariates:  
𝜑 = exp {∑ 𝛽𝑗  𝑋𝑖𝑗
𝑝
𝑗=1
} 
The model is often expressed in its logarithmic form with respect to time,  
log(𝑇𝑖) =  𝛽0 ∑ 𝛽𝑗𝑋𝑖𝑗 +  𝜎 𝜀𝑖
𝑝
𝑗=1
 
where 𝛽0 is an intercept, 𝛽𝑗 are the coefficients of the p covariates X, 𝜎 is a scale 
parameter and 𝜀𝑖 is a random variable that models the deviations of log(𝑇𝑖) from 
the linear part of the model; to the distribution of 𝜀𝑖 corresponds a distribution of 
the survival times 𝑇𝑖(Bradburn, 2003). The most used specification of the AFT 
model is indeed parametric, and many distributions can be used to best represent 
the time to event: exponential, Weibull (that can be used both as parametrization 
of the PH model and of AFT model), the log-logistic, log-normal or generalized 
gamma. Non-parametric specifications also exist, the most known being the 
Buckley and James method (Buckley I. V. 1979), but it is rarely used in real data 
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analysis for its problems in theoretical justification and robustness underlined by 
Wei (1992) and for the complexity of the computations.  
In AFT models, the effect of the covariate is measured on the survival times: 
this makes the interpretation of the results more immediate. The magnitude of the 
effect of covariates is not given in terms of hazard ratio, but of time ratio: if we 
divide the population in groups according to the level of a variable of interest, the 
time ratio stands for the ratio of the expected survival of a group with respect of 
the reference group. When >1, the covariate “slows down” the appearance of the 
event, while if it’s <1, it accelerates death. The model is fitted using the maximum 
likelihood method. 
Accelerated failure time models represent a valuable alternative to the Cox 
model when the assumption of proportional hazard is not realistic; nevertheless, 
they are not yet extremely diffused in medical and biological research as they are 
in the engineering field, where they are widely applied for reliability studies. 
Some of its characteristic make them appealing: as already mentioned, they are in 
many contexts more realistic, the parameters are more immediate to interpret, and 
choosing the wrong distribution affects the estimates less (Lambert, 2004) 
(Keiding, 1997) 
 
 
3.2.3 Unobservable heterogeneity and familiarity problem: 
univariate and shared frailty terms 
The methods for survival we have revised so far implicitly assume that 
individuals in the population are homogeneous; the analysis are performed to 
verify if differences exist and what determines diverse hazards. It can be the risk 
factor of interests, such as the tested compound, sex, age at the beginning of the 
treatment, but it is likely that other factors have an impact on the duration of life.  
Unlike in linear regression, it is very important to be sure that all relevant 
covariates are included in survival models in order to have unbiased coefficients 
and hazard rate. This is because the hazard rate is time dependent: suppose a 
characteristic divides the population in a low-risk group and a high-risk group. If 
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the characteristic is observed and modelled, two constant risks functions are 
estimated, one for each group; but if this variable is omitted, we will have one, 
common hazard function, decreasing in time since individuals from the high-risk 
group fail before than the others. When other covariates are included in the model, 
the effect of the omitted one will therefore alter the estimates of the parameters, 
because its distribution for each value of the included covariates varies with time. 
This was demonstrated in, among others, Gail et al. (1984), Schumacher et al. 
(1987), Bretagnolle and Huber-Carol (1988), Hougaard et al. (1994) Schmoor and 
Schumacher, 1997; Chastang et al, 1988. Bretagnolle and Huber-Carol also 
investigated the direction of the bias: their simulations showed that, no matter the 
number of covariates included in and omitted from the model, the effect of the 
observed variables will be underestimated, and the asymptotic bias changes the 
risk for confidence intervals from 5 to 50%.  
Very rarely nevertheless it is possible to observe all risk factors that affect 
survival. Experiments such as carcinogenicity bioassay have less problems than 
observational studies, thanks to randomization and careful experimental design, 
but still there are some sources of unobserved heterogeneity: sometimes it can be 
too expansive in terms of time or resources to measure and report all relevant risk 
factors with precision and completeness. This is the case with data from the Coca-
Cola experiments: basic information on the health status of the animals was 
observed and registered on a weekly basis on paper supports (we must remember 
that the experiment was carried out during the 80s): these data are still available, 
but they were not translated on informatic files since they are not usually used for 
analysis, so the information regarding the health of animals is essentially lost. 
This is the reason for the use of mixed effects in survival analysis: the idea is to 
decompose the variability of survival in two sources: a predictable part, measured 
by the coefficients of observed risk factors, and an unknown part, not directly 
observable, described by a frailty term. The concept was first elaborated by 
Greenwood and Yule in 1920, and developed after decades in Clayton (1978) and 
Vaupel et al (1979): individuals have different not observable characteristics that 
affect their survival probability, defined frailties, the more frail will survive less 
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than the less frail, creating a kind of selection that can give a distorted picture of 
the underlying process.  
Univariate frailties are random variables whose distribution reflect the nature 
of the relationship between the subject’s and population’s survival:  
ℎ(𝑡, 𝑍) = 𝑍 ℎ0(𝑡) 
They are time independent and act multiplicatively on the baseline hazard 
function, describing the unobservable heterogeneity among individuals (the 
variance of the frailty distribution determines the level of heterogeneity in the 
population: 𝐸(𝑍) = 1and  𝑉(𝑍) =  𝜎2, if 𝜎2 is small Z tends to 1 and the 
population is quite homogeneous).  
The survivor function is defined as  
𝑆(𝑡 | 𝑍) = exp {− ∫ ℎ (𝑠, 𝑍) 𝑑𝑠
𝑡
0
} = exp {−𝑍 ∫ ℎ0(𝑠) 𝑑𝑠
𝑡
0
} = exp{−𝑍 𝐻0(𝑠)} 
Frailties can of course be applied to the classic proportional hazard model 
containing other covariates, obtaining, for each subject, a hazard function of the 
form 
ℎ(𝑡, 𝑍, 𝑋) = 𝑍 ℎ0(𝑡) exp {∑ 𝛽𝑗𝑥𝑗𝑖
𝑝
𝑗=1
} 
 
Hougaard (1984, 1986a, 1986b) demonstrated that the survivor and density 
functions for the whole population, the only observable entities, and the mean and 
variance of the frailty are characterized using the Laplace transform of the frailty 
distribution as follows:  
𝑆(𝑡) = 𝐸 𝑆(𝑡|𝑍) = 𝐸 exp{−𝑍 𝐻0 (𝑡)} = 𝐿(𝐻0(𝑡)) 
𝑓(𝑡) =  −ℎ0(𝑡)𝐿
′(ℎ0(𝑡)) 
𝐸 𝑍 =  −𝐿′(0) 
𝑉(𝑍) =  𝐿′′(0) − (𝐿′(0))2 
These formulations clarify why it is important to choose a distribution for the 
frailty that has an explicit Laplace transform, and that maximum likelihood 
methods can be used for the estimation of regression parameters. The hazard 
function for the population becomes  
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ℎ(𝑡) = 𝐸 ( ℎ(𝑡, 𝑍)|𝑇 > 𝑡)
=  ∫ ℎ(𝑡, 𝑍) 𝑓(𝑧 |𝑇 > 𝑡) 𝑑𝑧 = 
∞
0
ℎ0(𝑡) ∫  𝑧 𝑓(𝑧 |𝑇 > 𝑡) 𝑑𝑧 
∞
0
 
or, taking into account the presence of covariates,  
ℎ(𝑡 | 𝑋) = ℎ0(𝑡) exp {∑ 𝛽𝑗𝑥𝑗𝑖
𝑝
𝑗=1
} 𝐸 (𝑍 | 𝑇 ≥ 𝑡, 𝑋) 
This explains that, since the frailer subjects die earlier, the average frailty of the 
survivors is not constant, but will decrease in time. 
Many types of distribution are possible for univariate frailties, usually 
parametric, like the Gamma distribution, the most widely diffused thanks to its 
mathematical properties: it’s always positive and has simple Laplace transform 
that allows to easily derive in closed forms the measures of interest, and most of 
all it is flexible, since it can take various shapes. Gamma-distributed frailty terms 
have been repeatedly used to model univariate and multivariate frailties, also in 
the analysis of survival in elderly population, so they have been considered for the 
analysis of these life-span experiments. Other possible parametric specifications 
are the positive stable, the inverse gaussian, the extended family of power 
variance function distributions, the lognormal and the compound Poisson, not 
suitable here since it creates a subgroup with Z= 0 that does not experience the 
event. If no information is available on the trait influencing the hazard among 
groups, the discrete specification is possible, both binary or finite discrete. The 
choice should be based on the knowledge of the phenomenon under study, but 
often simple mathematical convenience guides the selection.  
 
The Coca-Cola experiments have another peculiarity that can be addressed 
using frailty terms: young and adult rats were randomized using systematic 
sampling and assigned to treatment or control groups. After one week, they were 
also assigned for mating, and all the pups from all litters were included in the 
experiment, continuing the regime they were given during pregnancy and weaning 
through their dams.  
21 
 
Frailties are extremely useful also in this case, since they can be used to model 
dependence in cases where the implicit assumption of independence of each 
subject ad their failure times does not hold. This can happen when analysing 
recurring events, in studies where one patient act as his own paired control, or in 
studies where familiar groups are involved. The simplest option to overcome these 
independence issues are shared frailties: the idea here is that some of the 
unobservable characteristics that may affect the risk of failure are common among 
individuals belonging to the same cluster, like siblings, and they can influence the 
effect of observed covariates on survival. Here the random variable Zis constant in 
time and is associated to the group, instead of individuals, accounting for 
dependence among the subjects.  
The formalization of shared frailty models is due to Clayton (1978), and can be 
found also in Therneau and Grambish (2000) or Hougaard (2000). The survival 
times are independent conditional on the frailties, and the hazard takes the form  
ℎ(𝑡) = 𝑍𝑖ℎ0𝑗(𝑡) exp {∑ 𝛽𝑗𝑥𝑗𝑖
𝑝
𝑗=1
} 
where ℎ0𝑗(𝑡) is as usual the baseline hazard, that can be derived semi-
parametrically or parametrically, 𝛽𝑗are the regression parameters linked to the 
fixed effect of observable covariates and the frailties are defined by the 
parameters of their distribution, are independent between clusters and identically 
distributed, and shared by the individuals belonging to the same cluster. This way, 
the survivals are conditionally independent with respect to the frailties, and 
dependent inside the group, thanks to the frailty term. Supposing we had just two 
clusters, we would get  
𝑆(𝑡1, 𝑡2|𝑍) =  𝑆1(𝑡1)
2𝑆2(𝑡2)
2
= exp{−𝑍 𝐻01𝑡1} exp{−𝑍 𝐻02𝑡2}  = exp {−𝑍 ∑ 𝐻0𝑖𝑡𝑖
2
𝑖=1
} 
where 𝐻0𝑖(𝑡) =  ∫ ℎ0𝑖(𝑠) 𝑑𝑠
𝑡
0
. Again, the Laplace transform is extremely relevant 
to obtain the marginal survivor function:  
𝑆(𝑡1, 𝑡2) = 𝐿(𝐻01(𝑡1) + 𝐻02(𝑡2)) 
22 
 
As anticipated before, the standard distribution assumed for shared frailties is 
the Gamma, with mean 1 and variance 𝜎2, so the marginal survivor is denoted as  
𝑆(𝑡1, 𝑡2) = 𝐿(𝐻01(𝑡1) + 𝐻02(𝑡2)) 
         = (1 +  𝜎2 (𝐻01(𝑡1) + 𝐻02(𝑡2)))
−
1
𝜎2 
=  (𝑆1(𝑡1)
−𝜎2 + 𝑆2(𝑡2)
−𝜎2 − 1)
−
1
𝜎2 
The extension to multivariate case, with more than two clusters, is attributable to 
Cook and Johnson (1981), that defined the survivor function as 
𝑆(𝑡1, … , 𝑡𝑝 = (∑ 𝑆𝑖
𝑝
𝑖=1
(𝑡𝑖)
−𝜎2 − 𝑝 + 1)
−
1
𝜎2
 
with equal correlation among the survival of the individual belonging to the same 
group. This specification seems appropriate in such a case, where multiple litters 
are included, each composed by more than two siblings.  
An estimate of the frailty term within each litter can be found (Nielsen et al. 
1992) as 
𝑧?̂? =  
1 𝜎2 +  ∑ 𝛿𝑖𝑗
𝑛𝑖
𝑗=1⁄
1 𝜎2 +  ∑ exp {∑ 𝛽𝑗𝑥𝑗𝑖
𝑝
𝑗=1 }  𝐻( 𝑡𝑖𝑗)
𝑛𝑖
𝑗=1⁄
 
The properties of shared frailties survival models were demonstrated, both 
adding other covariates or not, in several works: Murphy (1994) showed its 
consistency and asymptotical normality (1995), Giddens (1999) tested for gamma 
distributions with the semiparametric survival function, and Cui and Sun (2004) 
demonstrated graphically and with numerical methods the adequacy of the 
Gamma distribution.  
Of course, the shared frailty approach has its limitations, and is not sufficiently 
flexible in several contexts: for example, it assumes that unobservable risk factors 
are equal among all individuals in each group, and that the association among 
subjects is positive in most of the cases (Xue and Bookmeyer, 1996). Since the 
characteristics of rats belonging to the same litter are extremely similar, there will 
be no need to consider more complex specifications for the multivariate frailty, 
like for example the correlated frailty model (where within each group a frailty 
term is associated to each individual: these random variables are positively or 
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negatively associated jointly distributed, and different distribution can be chosen 
to model different situations, like again the gamma, the log-normal or the 
compound Poisson).  
 
3.3 Analysis of time-to-event data from the Coca-Cola study 
As it was presented in the previous chapter, the Coca-Cola study involved 
randomized Sprague-Dawley rats of different ages, as well as their offspring, that 
was included in the observation in toto and without randomization. For all 
subjects the event of interest is spontaneous death, since these are life-span 
carcinogenicity studies and no terminal sacrifice was planned; subsequently, no 
censored observation exists, all subject experience the event. The outcome, then, 
is time to death, measured in weeks of age of each subject. All information about 
the identification of individuals were recorded at the beginning of the study: they 
are presented in the following table, and they represent the variables of interests, 
and the main other possible risk factors that we want to control:  
Variables Description Values 
Entry   Weeks of age at the beginning of the observation 7 weeks; 30 weeks; 39 
weeks; 55 weeks 
Age Duration of life (in weeks)  
Event Spontaneous death 1 deceased 
Treatment Experimental regime 0 drinking water (control); 
1 Coca- Cola (treated) 
Sex Sex 0 female; 1 male 
Momstart Age of the dam at pregnancy (only available for 
offspring) 
30 weeks; 39 weeks; 55 
weeks 
Famid Identifier for litters, common for all siblings born from 
the same breeders 
1-98 
Table 2: Variables for survival analysis; “setting” variables in italic, 
experimental variables in normal font. 
 
3.3.1 Descriptive analysis  
Here a brief summary of the data and some really basic descriptive statistics 
are reported:  
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Treatment Age at start M F 
Coca-Cola 7 weeks 80 80 
Drinking water 7 weeks 100 100 
Coca-Cola 55 weeks 70 70 
Drinking water 55 weeks 70 70 
Coca-Cola Offspring (55) 28 24 
Drinking water Offspring (55) 32 24 
Coca-Cola 30 weeks 55 55 
Drinking water 30 weeks 55 55 
Coca-Cola Offspring (30) 74 73 
Drinking water Offspring (30) 110 98 
Coca-Cola 39 weeks 110 110 
Drinking water 39 weeks 110 110 
Coca-Cola Offspring (39) 67 65 
Drinking water Offspring (39) 49 55 
Table 3: Composition of experimental groups; breeders and their offspring are 
listed sequentially. 
The experimental groups of breeders were formed to be balanced in terms of 
sex and treatment regime, but not in terms of ages groups. The offspring, since 
had not been randomized, present slightly less homogeneous characteristics, as it 
might be expected the pups born form older dams are fewer. A marginal analysis 
was used to highlight associations between the outcome and explanatory variables 
(Box-and-Whiskers plot and density plots are reported in Figure1).  
 
Figure 1: Age by experimental variables, Box-and-Whiskers plots 
The Box-and-Whisker plots don’t show significant alterations in the survival 
depending on sex, and the exposition to treatment seems to have a negligible 
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effect, too; the age at beginning of the observation and the age of the dams at 
pregnancy, on the other hand, determine more differences; these are confirmed 
when estimating the Kaplan Meier survival curves. Log-rank and Wilcoxon test 
were performed to verify the equality of survivor functions; they are not reported 
here for brevity, but they confirm the statistical significance of the differences 
among the curves calculated for animals entering in the experiment at different 
ages, for different ages of the dams, and surprisingly between rats belonging to 
treated and control group.  
 
Figure 2: Kaplan-Meier survival estimates for experimental groups 
According to the guidelines, the statistical analysis of these data could have 
stopped here. However, applying the methods that have been presented so far 
might give interesting insights on the problem, and more appropriate, robust and 
accurate results.  
 
3.3.2 Analysis of time-to-event for the first-generation’s rats  
We are dealing with two generations of animals, that, as we said, differ mainly 
because the first was randomized, while the second was not, so entire litters are 
present among the offspring. For this reason, it was chosen to separate the 
analysis and to apply to each generation the most suitable methodologies.  
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The analysis of survival times for the breeders started with the classic semi-
parametric Proportional hazard model, that was used to evaluate the influence of 
sex, treatment and their interaction. The variables were tested in univariate and 
multivariate models, and, coherently with the results of explorative analysis, 
treatment resulted the only experimental condition to represent an additional risk 
factor, increasing the probability of the event of about 11% for the subjects from 
the treated groups. As the plot of the estimated survivor function shows, the 
differences are not really marked, anyway. 
 
Figure 3: Estimated survivor function from the PH model, breeders 
 The exploration of the residuals showed that the overall fit of the model is 
very good, except for the last part, where the decreasing number of observation 
causes expectable issues; the plot of deviance and martingale residuals showed 
that some individuals could be too influential in determining the estimates, and 
the df betas and loglikelihood displacement helped individuate them. A careful 
examination of data confirmed that they don’t correspond to measurement or 
recording errors, and they fall in the range of plausible values, so they shall not be 
considered as outliers and excluded from the dataset. Schoenfeld residuals, “log-
log” plots and tests made to verify that the log hazard-ratio function is constant 
over time showed that the survival functions are not so different among the groups 
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we are considering, but that the assumption of proportionality of hazard is not 
tenable with respect to variable “sex”.  
 
Figure 4: Residuals to evaluate the assumptions underlying PH model, breeders 
Since the fundamental assumption of this approach is in doubt, it was decided 
for the use of the accelerated failure-time metric, and the evaluation of the effect 
of a univariate frailty has been included in the parametric AFT models only. The 
lognormal, loglogistic and generalized gamma distributions were tested in order to 
find the best parametrization for the model:  
Variables Lognormal Loglogistic Generalized gamma 
1.sex 0.005 0.003 0.021* 
1.treat -0.029* -0.034** -0.025** 
Constant 4.610*** 4.640*** 4.729*** 
Ancillary -1.283*** -1.902*** -1.533*** 
Kappa 
  
1.093*** 
    Log-likelihood -157.843 -112.815 -20.483 
AIC 323.686 233.630 50.966 
BIC 344.3665 254.311 76.817 
*** p<0.01, ** p<0.05, * p<0.1 
Table 4: Estimates and goodness-of-fit measures for different distributions of AFT 
models 
The comparison of the log-likelihood and AIC of each fit, together with the 
graphic representation of Cox-Snell residuals, showed that the generalized gamma 
is the best choices for the data.  
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Figure 5: Cox-Snell residuals for the evaluation of the best distribution for AFT 
models. 
No univariate frailty could be introduced in the Generalized gamma AFT 
model for computational problems of the software; it was tried therefore to fit a 
model with a univariate frailty term using the “second best” option, the 
Loglogistic distribution, that still showed a reasonable capacity to model the data. 
This compromise proved useless in the end, since the term to evaluate unobserved 
heterogeneity at the individual level was far from significant, and did not improve 
the fit of the model in any way. 
We can conclude that the survival experience of the animals belonging to the 
“first generation” group is best analysed using an accelerate failure-time model, 
and the most suitable distribution to represent their hazard function is a 
generalized gamma. 
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PH AFT AFT 
  
Generalized gamma Loglogistic 
Variables Coef  Coef  Coef 
1.sex -0.106* 0.021* 0.003 
 
(0.056) (0.012) (0.014) 
1.treat 0.109** -0.025** -0.033** 
 
(0.056) (0.012) (0.014) 
Constant 
 
4.729*** 4.642*** 
  
(0.012) (0.012) 
Ancillary 
 
.216*** -1.915*** 
  
(.005) (.0232) 
Kappa 
 
1.093 
 
  
(.074) 
 
Theta (gamma frailty) 
  
5.42e-09 
    Log-likelihood  -8009.919 -20.48326 -117.862 
AIC 16023.84 50.96653 245.724 
BIC 16034.18 76.81712 271.5746 
      Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1 
Table 5: Results of PH and AFT models for breeders, and measures of goodness 
of fit. 
The estimate coefficients confirm that the differences in survival among sexes are 
not relevant, while the treatment is responsible for a small but significant 
acceleration of the risk of the event (or, to be more straightforward looking at the 
negative coefficient, that the treatment causes the failure to happen more rapidly, 
so the expected time-to-event decreases). Residuals have been analysed mostly 
graphically, and they showed that the model is overall a reasonable representation 
of the data, and that there shouldn’t be major issues regarding the respect of the 
assumptions.  
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Figure 6:Residuals to evaluate the assumptions underlying AFT model, breeders 
 
3.3.3 Analysis of time-to-event for the second-generation’s rats  
The procedure that was followed to analyse the group of the offspring was 
essentially the same followed before: it started with the fitting and interpretation 
of a Cox model, whose assumptions were evaluated in order to assure its validity.  
The models were fitted to assess the effect of treatment on the risk of death, 
controlling for a possible effect of sex and of one more variable, the age of the 
dams at the beginning of gestation, that can take the values of 30, 39 or 55 weeks 
of age (in the dataset it is identified as “momstart”).   
Model 1- Proportional Hazard 
 
Coef Std. Err. z P>|z| [95% Conf. Interval] 
Observations 699      
1.sex 0.044 (0.076) 0.571 0.568 -0.106 - 0.193 
1.treat 0.182 (0.077) 2.373 0.018 0.032 - 0.332 
39.momstart 0.026 (0.085) 0.307 0.759 -0.140 - 0.192 
55.momstart 0.553 (0.112) 4.953 0.000 0.334 - 0.772 
      Log-likelihood -3870 
    AIC 7748.019 
    
BIC 
7766.218 
 
    
Table 6: Proportional hazard model, offspring 
As before, sex was not found to increase the risk of the event in a statistically 
significant way, while treatment has a relevant effect, so we can say that there is 
sufficient evidence to link a heavy consumption of Coca-Cola since prenatal life 
with an increase in the hazard of death; as expected, the later a dam undergoes 
mating, the higher becomes the risk of death for the pups: the risk for the pups of 
dams of 39 weeks is similar to those of 30, while for those bred by the oldest 
dams the risk increases sensibly.  
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Figure 7: Estimated survivor functions by sex, treat and age of dams, offspring 
The results showed that for this dataset the assumption of proportionality of 
hazard is realistic: even if Schoenfeld and scaled Schoenfeld residuals show some 
irregular trend, a formal test for the equality of log hazard-ratio over time 
excluded important violations. No observations were found to have an excessive 
influence on the estimates or on likelihood of the model, and globally it performs 
quite good for these data.  
 
Figure 8: Residuals for the evaluation of the assumptions underlying PH model. 
A frailty term was than introduced in the model, this time representing a proper 
shared latent random effect, considering each litter a cluster: its effect represents 
the common characteristics that individuals belonging to the same cluster 
verisimilarly share. It accounts for the possible association existing among them, 
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that would make unreasonable the assumption of independence of the subjects. 
Frailty terms are assumed here to be gamma-distributed with mean 1 and variance 
θ, and they affect the hazard multiplicatively; a significant shared frailty would 
confirm that correlation among members of the same litter exists (and the degree 
of the correlation is measured by θ), and is relevant in explaining survival 
patterns.  
 
Figure 9: Estimated survivor functions from PH model with a shared frailty term 
The term proved significant for the dataset of offspring: the effect of shared 
characteristics on survival is relevant and has to be considered. On the other side, 
it must be noticed that treatment loose of importance if this new variable is 
considered.  
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Model 2- Proportional hazard + shared Gamma frailty 
 
Coef Std. Err. z P>|z| [95% Conf. Interval] 
Observations 699 
    
Number of groups 98 
    
1.sex 0.048 (0.081) 0.587 0.557 -0.112 - 0.207 
1.treat 0.229 (0.125) 1.830 0.067 -0.016 - 0.474 
39.momstart 0.095 (0.138) 0.684 0.494 -0.176 - 0.365 
55.momstart 0.688 (0.172) 4.004 0.000 0.351 - 1.024 
theta .166 (.046) 
 
0.000 
 
      
Log-likelihood -3850 
    
AIC 7708.57 
    
BIC 7726.768 
    
Table 7: Estimates and goodness of fit of PH model with a shared Gamma frailty 
The post-estimation analysis for model validity and goodness of fit do not 
show major problems or violations in the assumptions underlying the model, 
neither regarding the presence of outliers, nor the proportionality of hazards, so 
for the second-generation group it was not necessary to look for a better 
specification using different metrics.  
 
Figure 10: Residuals for the evaluation of the assumptions underlying PH model 
with Gamma frailty 
 
Regarding the analysis of survival times, we can draw some conclusions: first, 
it is important to go beyond the plain comparison of nonparametric estimates. 
Indeed, mostly in case of complex data, or atypical ones, like those that were 
analysed here, where we had different generations and members of the same litters 
in experimental groups that were not created using randomization, the hazard of 
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death could be attributed to factors that are not of major relevance in reality. A 
good example comes from the survival experience of the second-generation rats: 
had we not included the shared frailty term, that accounts for unobservable 
common features of individuals (it can be a genetic predisposition for some kind 
of disease or tumours, the fact of belonging to a very numerous litter, where 
individuals are necessarily smaller and therefore possibly weaker, and so on), we 
might have attributed the observed differences in the times to death entirely to the 
treatment.  
Another caveat is to always bear in mind the importance of verifying that the 
methods that are chosen to analyse data are suitable for them, and that it is neither 
granted nor banal that all assumptions on which models are based, are always met. 
Here, the hypothesis of proportionality of hazard did not hold in the breeders’ 
dataset, and that emerged only after the examination of the residuals; the 
importance of model checking is clear for statisticians, but the same can’t be 
assumed for all researchers from different fields that follow the whole experiment, 
included data analysis.  
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Chapter 4 The analysis of longitudinal data  
 
 
Data collected measuring one or more variables of interest in repeated 
occasions over the same set of subjects, that we assume to constitute a random 
subsample of the population of interest, are often referred to as repeated measures 
data. When repeated measures are ordered in time or space, and we cannot assume 
that the observations within each individual has been assigned randomly, we call 
these data longitudinal. When they are available, individual patterns of change 
can be observed: longitudinal data can thus provide richer information, but request 
particular attention, since the drop out of the individuals under study represent in 
some applications an important issue (clearly not in our case), and correlation 
rises among observations registered for the same subject. 
Long-term and life-span carcinogenicity experiments often request several 
types of longitudinal data: measurements of body weights and mean consumption 
of food and beverages for cage are routinely collected with quite dense schedule, 
since they are an important track of the animal well-being and of the good course 
of the experiment itself (OECD 2002). They should be monitored jointly, since 
changes in body weight can be related to alterations caused by interactions 
between nutrients and the tested substance, or by a different palatability of foods. 
Sensitive changes (in particular losses) may be important signals of health 
problems, and should be always regarded with attention. These indicators also 
gain importance per se because they are heavily related to metabolic, hormonal 
and homeostatic functions, growth and sexual maturation. In this study, where the 
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tested compound is a highly caloric and sugary beverage, body weight in 
particular should be of primary interest, in association with classic tumour 
incidence, since it is well established that overweight and obesity are positively 
associated with the increase of risk of many types of cancer. Based on a 
systematic review of the published scientific literature, IARC assessed that the 
absence of excess body fat has a preventive effect in humans for cancers of the 
colon and rectus, oesophagus, kidneys, breast and endometrium, and, with 
sufficient evidence, for cancers of the gastric cardia, liver, gallbladder, pancreas, 
ovaries, thyroid, meninges, and on multiple myeloma (Lauby-Secretan B 2016).  
 
4.1 The analysis of longitudinal data according to the guidelines  
In usual carcinogenicity studies, nevertheless, body weight variations and food 
consumption do not directly represent the primary outcome of interest, so their 
analysis is, again, not particularly thorough. Guidelines (OECD 2012) suggest to 
represent graphically group means, to promptly identify unexpected trends; this is 
most important in during the early to middle part of life, while after approximately 
80 weeks of age the rodents enter the geriatric phase, and are more prone to 
weight losses due to ageing, diseases or tumours; also, it was noted that lighter 
rats tend to live longer than heavier ones, so means might be biased downwards. 
Formal analysis of data always refers to body weights and food consumptions by 
timepoint of interest and averaged on groups, since no methodology for repeated 
measures is explicitly advised. It should start with a test to identify the presence of 
outliers, like the Dixon and Massey test, followed by a test to evaluate the 
assumption of normality (either the Kolmogorov-Smirnov or the Shapiro-Wilk 
test). In case of not-normally distributed data, a logarithmic transformation is 
suggested, and the test repeated. If data fall back into normality assumption, 
another test for outliers such as the Extreme Studentized Deviate statistics could 
be carried out; then the F-test, or the Levene’s or Bartlett’s tests can be performed 
to evaluate the homogeneity of variance, respectively if the experiments has two 
or more groups. If the F-test highlights that variances are homogeneous, a 
Student’s t-test can be used to evaluate differences between groups, while if they 
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are heterogeneous the comparison is performed with the modified t-test, using 
Satterthwaite’s method. In presence of more than two groups having 
homogeneous variances, the comparison between all groups can be performed 
using one-way ANOVA followed by Duncan’s multiple range test or Tukey’s 
Honest Significant Difference test, and by Dunnett’s test for pair-wise 
comparisons between the control and the dosed groups. If the assumption of 
normality is not tenable even after transformation and analysis of outliers, or if the 
Levene’s test shows that variances are heterogeneous, some alternative methods 
are suggested: the Kolmogorov-Smirnov’s test or the Wilcoxon rank sum test can 
be used to compare two groups, while global differences among more 
experimental groups can be tested with a Kruskal-Wallis ANOVA by ranks, or a 
Jonckheere’s test. If significant differences are found, multiple comparisons are 
possible using distribution-free methods like Dunn’s or Shirley’s tests. A concise 
representation of the suggested analysis can be seen in Figure 1.  
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Figure 11- OECD statistical decision tree summarizing procedures for the 
analysis of continuous data 
The approach suggested in the guidelines is one of the many that have been 
developed based on the analysis of variance since the beginning of XX century: 
the foundation goes back to the work of the astronomer G. Biddel Airy, and was 
later formalized by R. A. Fisher (Fitzmaurice G 2008).Several approaches took 
the moves from the ANOVA paradigm, and the one just described is probably one 
of the simplest, since it consists in summarizing the collection of measurements 
for each individual in a single or a set of values, that are than compared using the 
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ANOVA method. Means are a very immediate measure, and the area under the 
curve (AUC) is also quite common. Appealing for its simplicity, this approach has 
clear drawbacks: the loss of information, and the fact that completely different 
series of data can produce the same summary measure; the impossibility to 
evaluate the effect of time-varying covariates; the violation of the assumption of 
homogeneity of variances at the basis of ANOVA, that is very likely when 
measurements are irregular, not equally spaced or have missing data.  
Another possible method, one of the earliest, was the mixed-effect ANOVA, 
also referred to as the univariate repeated-measures ANOVA: since the structure 
of longitudinal data shows some similarities to that of data from randomized block 
designs, for which ANOVA had been developed, the methodology was applied to 
repeated measures data, regarding the individuals as the blocks. The model can be 
written as  
𝑌𝑖𝑗 =  𝑋′𝑖𝑗 𝛽 +  𝑏𝑖 + 𝑒𝑖𝑗 
with i = 1, …, N individuals and j = 1, …n measurements, where 𝑋′𝑖𝑗 is a design 
vector, 𝛽 a vector of regression parameters, 𝑒𝑖𝑗~N(0, 𝜎𝑒
2)and 𝑏𝑖~N(0, 𝜎𝑏
2) doesn’t 
stands as the proper block effect anymore, but as a random subject effect 
representing the unobserved or unmeasured characteristics that cause differences 
in the outcome in each subject. This factor accounts for positive correlation 
among subsequent measurements within-subject, but is forced to follow a quite 
restrictive structure of the covariance, maintaining constant variance and 
covariance ( 𝑉𝑎𝑟(𝑌𝑖𝑗) =  𝜎𝑏
2+ 𝜎𝑒
2, and 𝐶𝑜𝑣(𝑌𝑖𝑗𝑌𝑖𝑘) =  𝜎𝑏
2).  The assumed 
compound symmetric structure of the covariance matrix is not the best for 
longitudinal data since correlation is likely to decrease as separation in time 
increase, and sometimes the variance does not hold constant in time. Some 
shortcomings of the model were addressed in time: Greenhouse and Gassier 
(1959) proposed an adjustment to handle more general covariance structure, while 
Henderson (1963) developed a method for unbalanced data. Anyway, the idea of 
allowing for random differences among subjects is the basis of various subsequent 
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regression methods, so the univariate repeated-measures ANOVA can be 
considered as a precursor of the regression methods that will be addressed later.  
A slightly more complex method was also used for the analysis of longitudinal 
data, the repeated-measures analysis by MANOVA, or repeated-measures 
ANOVA, a special case of MANOVA that handle multivariate, correlate data, and 
allows less stringent assumptions on the structure of the covariance matrix 
(covariances are only assumed homogeneous across subjects). This method, too, 
has some limitations, since it can’t handle time-unbalanced designs and missing 
data, leading to inefficiencies and possibly biased results.  
These methods can be used for longitudinal data after verifying their 
suitability, but their limitations must be kept in mind; more sophisticated and 
flexible methods are available. They will be exposed and applied to the Coca-Cola 
experiment data, and their usefulness evaluated.  
 
 
4.2 Other methods for longitudinal data 
4.2.1 Linear mixed-effects models  
Mixed effects models are likely the most widely used tool for continuous 
outcomes whose residuals distribute normally but are not independent or 
homoscedastic: these are characteristics of “grouped” data, where grouping may 
arise from clustering (measuring outcome on pups from the same litter for 
example), or from repeated measurements or longitudinal studies, where 
individuals are assessed repeatedly over time or under different experimental 
conditions. The correlation between measurements arising from the feature of the 
data is conveniently addressed in these models thanks to the possibility to choose 
between several types of parsimonious covariance structures.  
Furthermore, the basic idea of having a common functional form for all 
individuals, with parameters that vary among subjects is quite intuitive and can be 
appropriate in numerous situations. Indeed, these models are called “mixed” since 
they can incorporate explicative variables as fixed or random effects: fixed effects 
are associated to continuous or discrete covariates, and represent unknown 
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parameters that are constant in the population, for each level or value of the 
associated independent variable. When the levels of a categorical variable can be 
considered as random realizations of a sample space, and they are not of particular 
interest per se, they can be modelled as random effects.  
Its foundations lie in the ANOVA paradigm, as can be seen in the works of 
Scheffé (1959) and Harville (1977), but also in the idea of allowing for random 
differences across individuals when analysing growth curves, as in Wishart 
(1938), Box (1950), Rao (1958), Potthoff and Roy (1964), and Grizzle and Allen 
(1969). Another contribution in the development of mixed-effect model was the 
two-stage approach, adopted and made popular by the US National Institute of 
Health. According to this approach, the distribution of the repeatedly measured 
outcome is the same for all subjects and is characterized in the first stage, but the 
parameters can vary randomly over the units (so they also can be referred to as 
random effects), and their distribution constitutes the second stage of the model. 
Laird and Ware (1982) were the first to propose a flexible class of mixed 
models for longitudinal data: it includes bot growth and repeated-measures 
models as special cases, and introduces population parameters, individual effects 
and within-subject variation, as well as between-subject variation. 
In their representation, the 𝑛 ∗ 1 vector of responsesfor the ith subject can be 
modelled as  
𝒚𝑖 =  𝑿𝑖𝜷 +  𝒁𝑖𝒃𝑖 +  𝜺𝑖                       𝑖 = 1, … 𝑁  
where  
• 𝑿𝑖𝑗 is a 𝑛𝑖 ∗ 𝑝 design matrix of explanatory variables or fixed factors; 
• 𝜷 is a 𝑝 ∗ 1 vector of unknown population parameters, or fixed effects 
coefficients, describing the relationships between the outcome and the 
explanatory variables for group defined by levels of a fixed factor (for 
example, describing the contrast between males and females);  
• 𝒁𝑖 is a 𝑛𝑖 ∗ 𝑞  design matrix of variables orrandom factors; 
• 𝒃𝑖 isa𝑞 ∗ 1vector of unknown random effects, specifically referred to a 
given level of a random factor, usually representingthe deviations from the 
relationships described by fixed effects. Random effects can be set as 
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random intercepts (random deviations for an individual or cluster from the 
overall fixed intercept), or as random coefficients (random deviations for 
an individual or cluster from the overall fixed effects). They are assumed 
to follow a multivariate normal distribution (~ 𝑁(𝟎, 𝑫)), with𝐷being a 
𝑞 ∗ 𝑞symmetric, positive definite variance-covariance matrix;  
• 𝜺𝑖 is a𝑛𝑖 ∗ 1vector of errorsfor the ith subject for each measurement 
occasion, whose terms do not need to be independent but can be correlated 
within individual. The residuals for each subject follow, again, a 
multivariate normal distribution (~ 𝑁(𝟎, 𝑹𝒊 )),with 0 mean and a positive 
definite 𝑞 ∗ 𝑞 variance-covariance matrix,𝑹𝑖 . 
Several covariance structures can be specified both for D and for 𝑹𝒊 4. For D, a 
very common definition is the unstructured, where no additional restriction is 
assumed on the value of its elements apart from positive- definiteness and 
symmetry, so the variance components to be estimated are 𝑞 ∗ (𝑞 − 1) 2⁄  (the 
variance 𝜎𝑏
2  for each of the 𝑞 random effects and the covariance 𝜎𝑏𝑘,𝑏𝑙 for each 
couple). Other more parsimonious covariance structures are possible, but they 
require more constraints: an example isthe diagonal matrix, where only the 
variances are estimated, while the covariances are set to 0. The simplest 
specification for 𝑹𝒊 is the diagonal structure, that require the estimation of one 
single parameter for the variance component, 𝜎𝑏
2, since the residuals are assumed 
to be uncorrelated within individual, and to have common variance. The 
covariance matrix can alternatively take a compound symmetry structure, that 
assumes equal variances and equal covariances among observations within 
subject, and is suitable for example for repeated assessments under the same 
experimental conditions, when equal correlation of the residuals is plausible. 
Another quite common structure is the 1st order autoregressive or AR(1), under 
which the variance components vector only contains two parameters, the variance 
𝜎𝑏
2, that is assumed constant and always positive, and a correlation parameter ρ, 
whose values go from -1 to +1; the covariance is calculated as 𝜎𝑏
2𝜌𝑤, where 
                                                          
4The following presentation of Linear Mixed effect models is based on the work of West et al. 
(2010) 
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𝑤 represents the lag between observations within subjects (so for adjacent 
observations is higher, and tends to 0 for very far observations): this makes it 
suitable for equally spaced experimental designs. Other structures, with less 
constraints, are possible, but are less parsimonious, and require the estimation of 
more parameters of the variance components. Mixed models even allow to assume 
that subjects characterized by different levels of variables may share the same 
structure of the covariance matrix, but have different values for the parameters of 
the vector of variance components of D and 𝑹𝒊 .  
 
An alternative specification of the mixed effect model, referred to all 
individuals together, is given as 
Y = Xβ + Z u + ε, where u∼ N (0, G) and ε∼ N (0, R) 
Here Y, u and ε are vectors obtained from “stacking” respectively the Yi, ui and 
εi vectors for all subjects vertically, the n × p design matrix X is obtained by 
stacking all Xi matrices vertically and the Z matrix is a block-diagonal matrix, 
with blocks on the diagonal defined by the Zi matrices. The G matrix is therefore a 
block-diagonal matrix containing the variance-covariance matrix for all random 
effects, with blocks on the diagonal defined by the D matrices, while the n × n 
matrix R is a block-diagonal matrix of variance-covariance for all residuals, where 
the Ri individual matrices define the blocks on the diagonal.  
Since it is assumed that the random effects and the error terms follow a normal 
distribution, the whole model can be written marginally as 
𝒚𝑖 =  𝑿𝑖𝜷 +  𝜺𝑖  
where𝜀𝑖 ~ 𝑁(0, 𝑉𝑖 )and 𝑉𝑖 =  𝑅𝑖 + 𝑍𝑖  𝐷 𝑍𝑖
′ , with the covariances of the 
observations (the off-diagonal elements) allowed to be correlated, so different 
from 0. Consequently, the marginal distribution of the vector of responses is 
defined as 𝑦𝑖 ~ 𝑁(𝑋𝑖 𝛽, 𝑅𝑖 + 𝑍𝑖  𝐷 𝑍𝑖′ ). This representation is worth being 
reminded since it’s in this framework that are estimated the fixed effects and the 
variance components in most statistical software, and lies at the basis of the 
likelihood approach for estimation.  
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Inference on the parameters estimates can be based on least squares and 
maximum likelihood methods, or, formulating the model the appropriate way, 
using an empirical Bayesian method. Under the classical frequentist approach, 𝛽 
and 𝜃 (where 𝜃 is a 𝑞 ∗ 1 vector containing the variances and covariances from 𝑅𝑖 
and 𝐷) can be obtained maximizing the likelihood function, as usual: the 
likelihood is set as a function of the parameters of the hypothesized model, taking 
all assumptions into account: for the mixed effect model, the marginal 
specification of the model is used. The values of the parameters that, given all 
assumptions, make the observed values of the outcome most likely, are the 
maximum likelihood estimates for the parameters. The likelihood function 𝐿(𝛽, 𝜃) 
is given by the product of all individual likelihood functions, and the log-
likelihood is found as usual, as the natural logarithm of the likelihood function, 
resulting in 
𝑙𝑀𝐿(𝛽, 𝜃 | 𝑦) =  −
1
2
[𝑛 ∙ log(2𝜋) + log(𝑽𝑖) + ( 𝑦𝑖 −  𝑋𝑖 𝛽)𝑽𝑖
−1( 𝑦𝑖 −  𝑋𝑖 𝛽)] 
The estimates of the covariance parameters are obtained using iterative 
procedures, until the reaching of convergence; once the ML estimates of θ are 
found, they are used to compute (directly) the estimated value of 𝑽𝑖, and finally to 
calculate the generalized least square for the regression parameters β. Since an 
estimate of the values in 𝑽𝑖are used, the βs are also called the empirical best 
linear unbiased parameters. The main problem with maximum likelihood 
estimates of the variance components, is that they do not account for the degrees 
of freedom used to estimate the parameters of β, so they are biased, as discussed 
in Verbeke & Molenberghs (2000). To overcome this issue, the Reduced 
Maximum Likelihood estimates are more often used. REML was proposed 
initially to overcome the problem of the estimation of variance components from 
unbalanced or incomplete block design, and was then adopted as an alternative 
tool and even preferred to classical ML method since the estimates are not biased, 
because the degrees of freedom used for the estimation of the fixed effects are 
considered. This allows to obtain estimates of the values in the 𝑽𝑖 matrix; then the 
parameters of the β can be found using the methods from ML approach, using 
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generalized least squares. The estimates obtained with the REML and ML method 
are different: for β, ML produces biased results, while REML does not, as already 
mentioned; for the variances of β, both methods give results that are biased 
downwards, because neither compensates the uncertainty coming from the use of 
empirical estimates of 𝑽𝑖. Usually, this problem is overcome trying to find the 
best possible estimates of the 𝑽𝑖, using REML to fit models with alternative 
structures for D and 𝑹𝒊 .  
The estimation of the covariance parameters (that is, the maximization of the 
log-likelihood function under the assumption of positive-definite matrices D and 
𝑹𝒊 )is usually perform using the Expectation-maximization algorithm, the 
Newton-Raphson procedure or the Fisher scoring algorithm. In most statistical 
software, first appropriate starting values for the parameters are estimated with the 
EM algorithm; these are then used for the following estimations, using the 
preferred algorithm. The most common method is the Newton-Raphson, both for 
ML and REML.  
Mixed effects models have also proved to be robust in the analysis of 
unbalanced data when compared to the General Linear Model framework 
(Pinheiro and Bates, 2000): individuals with incomplete observations can still be 
included in the analysis, and with complete data, too, mixed effects models 
provide advantages over the GLM. 
So far, the response variable for individuals was assumed to follow a linear and 
continuous trend, but often it can present discontinuities, or show a nonlinear 
path, making reasonable the assumption that the likelihood function may depend 
on the parameters in a non-linear way. It is the case of several physical 
phenomena, and growth is the main example. Several adaptations may be adopted 
to cope with these situations, the most common being the splitting of the time of 
analysis into subperiods, so that the linearity assumption underlying the model is 
reasonable within each one. The drawback of this simple solution is that it 
prevents from analysing the phenomenon under study in its richness, treating 
discontinuities and nonlinearities as problems to overcome to fit the data to the 
model, rather than as the characteristics of the process itself.  
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Two approaches can be tried in this situation (Singer J. D. 2003): the first is 
more empirical, based on the observation of individual trajectories and the 
manipulation of data. One possibility is to identify a suitable transformation of the 
outcome or the time scale that can lead to a linearization of the trajectories for 
each individual, so that the assumption of linearity holds, and the simpler model 
illustrated so far can be fitted. Many ways to transform data of course exist, and 
the most suitable must be found every time through several tries5.Another 
possibility is to introduce in the model different predictors that all together 
characterise time, that is, to represent time as a polynomial function. So, a second-
order polynomial may be fitted to account for trajectories that resemble quadratic 
change with one stationary point; a third-order polynomial will account for cubic 
change, and so on. The main issues with this device is the increased complexity of 
the model and the interpretability of the regression parameters. The second 
approach is more theory-based, and requests to identify a reasonable functional 
form underlying the trend of subject’s data, that will be used in the model to 
describe the relationship between the response and explicative variables. As we 
will show in the next paragraphs, both strategies have been applied to the body 
weights data of the second generation of rats from the Coca -Cola study.  
 
4.2.2 Nonlinear mixed effects models  
The general model presented in the previous paragraph and all the expedients 
that allow to represent growth trajectories of many shapes share a characteristic: 
they imply an association linear in the parameters between the outcome and the 
explicative variables, because the model is composed by individual growth 
parameters, that are linked in a linear way. Often however, the likelihood function 
depends on the parameters in a non-linear way: it is the case of several physical 
phenomena, and growth is the main example. In such cases, the use of nonlinear 
model is justified by the possibility to obtain a more interpretable model, and to 
                                                          
5A useful tool to have an idea of the possibilities is given in Mosteller and Tuckey (1977), where 
the ladder of transformation is associated to the so-called rule of the bulge (the idea is to associate 
the approximate shape of the plots to a suitable transformation of the outcome or time, to be 
applied to all individuals) 
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use a smaller number of parameters, mostly if we compare them with high-order 
polynomial models. 
Lindstrom and Bates (1990)were the first to present a general, nonlinear mixed 
effects model for data in which the assumption of the normality of residual holds, 
but the expectation function is nonlinear. The model can be written as  
𝑦𝑖𝑗 = 𝑓(𝑥𝑖𝑗 , 𝛽, 𝑢𝑖) + 𝜺𝑖𝑗,              𝑖 = 1, … , 𝑁 
where𝑓 is a real valued function, 𝑥𝑖𝑗is a vector of covariates containing both 
within- and between-subjects covariates, 𝛽 is a 𝑞 ∗ 1  vector of unknown 
parameters of fixed effects, 𝑢𝑖 is a vector of unobservable subjective random 
parameters following a multivariate normal distribution with 0 mean and 
variance-covariance matrix 𝛴, and𝜀𝑖 is the usual error vector of dimension 𝑛𝑖 ∗ 1, 
following a multivariate normal distribution with 0 mean and variance-covariance 
matrix 𝜎2𝛬.  
It is useful to adopt the two-stages representation of the model6, since it helps 
clarifying how the non-linear function is used to express the individual trajectory 
of change at level 1 
𝑦𝑖𝑗 = 𝑚 (𝑥𝑖𝑗
𝑤, 𝜑𝑖) + 𝜀𝑖𝑗,  
where m describes the behaviour of the individual growth as depending on 
individual-specific parameters 𝜑𝑖 and the vector of within-subject covariates 𝑥𝑖𝑗
𝑤, 
while the inter-individual variability can be expressed using a regular linear 
relationship at level 2: 
𝜑𝑖 = 𝑑 (𝑥𝑖𝑗
𝑏 , 𝛽, 𝑢𝑖) 
where d is a vector function that explains the variation of individual-specific 
parameters between subjects, and incorporates 𝛽, the vector of parameters for the 
population, and 𝑥𝑖𝑗
𝑏 , the set of between-subjects covariates.  
The assumptions underlying the non-linear mixed effects model are that the 
random effects 𝑢𝑖and the error terms 𝜀𝑖 are independent between each other and 
across individuals, that 𝜎2 > 0 and that matrix Σ is definite nonnegative.  
                                                          
6The following presentation of nonlinear mixed effect models is mainly based on the work of 
Demidenko (2013) 
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An important part of the modelling process regards the choice of which 
parameters to consider random, so individual-specific, and which can be regarded 
as population-averaged, so fixed.  
A specific feature of NLME models is that the random parameters 𝜑𝑖  appear in 
a nonlinear function, implying that the expected value of the response can’t be 
expressed in closed terms, in terms of population averaged parameters. This 
makes it is very difficult to establish the statistical properties of the model in small 
samples; indeed, even the condition of a number of subjects N tending to infinity 
while the number of observations for each individual 𝑛𝑖remainis finite, that is a 
sufficient condition for linear mixed effect models to be consistent, asymptotically 
normal and efficient, is enough only for maximum likelihood estimation. 
Maximum likelihood estimation, yet, requires the integration of the unobservable 
individual-specific parameters, and this leads to the presence of a 
multidimensional integral. To avoid this problem, various approximation methods 
for the estimation of the model exist. They can be grouped into two categories, the 
two-stage methods, and those that approximate the NLME function to a linear 
function, to reduce the model to a nonlinear marginal mixed effects model. In the 
former methods, nonlinear least squares are used to estimate individually the 
subject-specific parameters from the first stage; then these are used as 
observations for the second stage model. These methods can be proficiently used 
to when  𝜎2 is relatively small, and the number of observations for each cluster 
relatively large. The latter methods allow to obtain good approximations when an 
estimate of the random effects from the penalized nonlinear least square estimator 
is used. All methods, anyway, become equivalent when the number of clusters 
and of observations for each cluster tend to infinity. As already mentioned, the 
ML estimator is consistent when the number of subjects tends to infinity and the 
number of observations for each individual remains finite, but this characteristic 
can be lost if the distribution of the random effects is mis-specified (however, if 
also the number of observations per cluster tend to infinity, we can consider it 
consistent even if the distribution of the random effects is not appropriate).  The 
ML estimator also returns correct standard error for all estimates.  
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Choosing the correct functional form for the model is very important: the 
choice of a not suitable model may prevent convergence, produce negative 
variances for the random effects, computational difficulties and so on. The 
observation of individual growth paths can ease the choice, but a theory-driven 
approach is possible, as it will be illustrated in the next paragraph. The growth and 
maturation processes have been long studied in humans, and several models have 
been proposed to formalize the growth patterns during infancy, childhood and 
adolescence. Since some similarities can be recognized in the growing process of 
very young humans and rats, some of these models have been “borrowed” and 
applied here.  
 
4.2.3 Growth models  
The analysis of the progress of growth and maturation in humans has a long 
history. It covers the study of variations of stature and weight, and of the velocity 
of growth standardized relative to the passage of time, as well as of the acquisition 
of secondary sexual characteristics, to investigate the progressive achievement of 
adult status. Describing the normal progress of childhood growth is important per 
se, and even more interesting is the study of any variation from the regular 
pattern: differences in size, velocity and timing of maturation can give indications 
on health problems at different levels. In normal conditions, indeed, growth is 
determined by the personal genetic complement and ruled by several hormonal 
systems, but many and various environmental factors, first of all nutrition, 
represent a fundamental constraint.  
Auxological studies always looked at mathematics to formalize and model the 
normal growth phases7, starting from the observation and measurement of 
individuals under study. They usually are of two types, with different goals: cross-
sectional studies usually aim at obtaining age-dependent reference curves, while 
longitudinal studies have the purpose to understand the growth process over some 
period.  
                                                          
7The illustration of growth models is mainly based on the work of Hauspie et al, 2011.  
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Longitudinal data and the will to understand the growth process and highlight 
possible differences due to the treatment regime is what we have in the context of 
this study on rats, too, so these methods were applied to this unusual field.  
It is well established that the pattern of growth of body dimensions of the 
“general type” (to be distinguished from those of lymphoid, neural and genital 
type) is increasing and S-shaped, from birth to the adult age, since it progresses 
rapidly in the first years, then slows down, and accelerates again around the so-
called pubertal spurt, to become a plateau when the approximate adult size is 
reached. Simple linear regression is therefore clearly not the best tool to manage 
this kind of data. As already mentioned in the previous sections, polynomial 
models are sometimes used to represent longitudinal growth data, since they are 
computationally convenient, but they are preferred for small periods, and their 
major drawback is the difficult interpretation of the higher-order terms.  
Another interesting alternative might be the use of smoothing methods, that can 
help highlighting the shape of growth form “noisy” data, estimating a curve 
without an a priori fixed parametric model. The most used techniques are 
smoothing splines, kernel estimators, or local polynomials. They may represent a 
good alternative in this case, where a lot of observations were registered at quite 
close measurements, so data might be prone to measurements errors and short 
terms variations.  
Regression models based on an adequate parametric function would be the best 
alternative, since they are estimated using fewer parameters that have some 
biological interpretation, but they are quite insidious: the choice of the appropriate 
functional form is difficult, it is necessary to consider all the facets of the growth 
process to reduce the risk of obtaining biased results, and their estimation is 
computationally quite demanding. 
Several models have been developed in time to represent phases of growth: 
most structural models are monotonously increasing functions, that were designed 
to describe the growth of dimensions for which only rising values are possible, 
and only during the initial part of life (mostly infancy, more rarely adolescence), 
so their appropriateness to model body weights during the whole lifespan must be 
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carefully evaluated; here only a small selection will be presented and applied to 
data. 
All will be illustrated as if they were referred to the individual: all functions, 
indeed, can be substituted to the generic function at the level 1 of the nonlinear 
multilevel mixed effect model that was illustrated before, since they describe the 
behaviour of each individual. 
The first parametric model was elaborated already in 1937 by Jenss and 
Bayley: it was developed to describe data from birth to approximately 8 years 
using 4 parameters combined in a function with a linear and an exponential part, 
accounting for growth and its decreasing rate:  
𝑦 = 𝑎 + 𝑏 𝑡 −  𝑒𝑐+𝑑 𝑡 
Another option is the Count model proposed in 1942, that uses only 3 
parameters combined in a linear way  
𝑦 = 𝑎 + 𝑏 𝑡 + 𝑐 ln(𝑡 + 1) 
This model proved to perform slightly worse than the Jenss and Bayley, but 
both share the quality of remaining robust relative to the choice of starting values 
for the parameters. The Count model was slightly modified in 1973 by Berkey and 
Reed in a way that maintained the simple, linear structure but added one or two 
parameters 
1𝑠𝑡  𝑜𝑟𝑑𝑒𝑟:  𝑦 = 𝑎 + 𝑏 𝑡 + 𝑐 ln(𝑡 + 1) +
𝑑
𝑡
 
2𝑛𝑑  𝑜𝑟𝑑𝑒𝑟:  𝑦 = 𝑎 + 𝑏 𝑡 + 𝑐 ln(𝑡 + 1) +
𝑑1
𝑡
+  
𝑑2
𝑡2
 
accommodating for one or two additional inflection points (and so allowing to 
consider periods of acceleration), and leading to a better fit compared to the 
previous alternatives.  
Adolescence growth was initially analysed using the logistic function 
𝑦 = 𝑝 +
𝑘
1 +  𝑒𝑎−𝑏 𝑡
 
and the Gompertz function 
𝑦 = 𝑝 + 𝑘 𝑒−𝑒
𝑎−𝑏 𝑡
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 because they well reflected its main features of a sigmoid trend, starting from 
a lower “asymptote”, experiencing a sharp increase in velocity and, after an 
inflection point, a decline in the growth rate until the approximation to the upper 
asymptote, the adult size. Both models proved to perform quite good, but they 
required the lower age bound (the cut-off between childhood and adolescence) to 
be determined arbitrarily, so their use became limited in time, in favour of 
alternatives, such as the Preece-Baines model. Several models were also proposed 
for the analysis of growth from birth or early childhood until adult age form the 
‘80s, all sharing the fundamental idea of combining different (at least two or 
three) functions, so that each component could describe the type of growth typical 
of a smaller period of life. The first were the double- and triple- logistic functions, 
composed by the sum of separate logistic functions, each to model infancy, mid-
childhood and adolescent phases. These were modified by Bock and colleagues in 
1994 replacing each logistic with a generalized logistic function; more options 
were provided, between other, by Shohoji- Sasaki who proposed the Count-
Gompertz function in 1987, or by Jolicoeur and colleagues, that created the JPPS, 
the JPA-1 and JPA-2 models. Despite all these methods would be extremely 
interesting to analyse more in depth, they will not be further treated here, since 
they were created specifically to model height/length instead of weight, and they 
were formulated quite specifically to render the human progress from infancy, 
trough childhood, the so-called take off, the whole adolescence spurt, until 
adulthood. Our data hardly share these characteristics, so simpler models will be 
preferred.  
 
4.3 The analysis of body weights  
The analysis of body weights in the first generation of rats, those originally 
randomized and involved in the experiments, was not performed here, but it was 
chosen to study only the rats belonging to the second generation, since their 
characteristic make them more interesting, challenging, and overall more worth a 
thorough analysis.  
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We can say that their treatment started in the pre-natal phase, because their 
dams underwent mating and started gestation one week after the beginning of the 
experiment, when they were already exposed to the treatment or control regime; 
moreover, they continued the exposure during the whole period of the pregnancy 
and the weaning. The observation of the second generation of rats started at 8 
weeks of age8, when all pups have certainly reached a complete independence 
from their dams. 
Age of dams 
Males Females 
Treated Control Treated Control 
30 weeks 74 110 73 98 
39 weeks 67 49 65 55 
55 weeks 28 32 24 24 
Total 169 191 162 177 
Table 8: Rats by sex, treatment and age of dams at start of gestation 
Male and females from treated and control groups are quite balanced, while 
there is an important decrease as the age of the dams at the beginning of gestation 
increases, as we would physiologically expect.   
Measurement 
Missing 
n % 
Week 9 (1 of observation) 0 0 
Week 30 13 0,018 
Week 70 78 0,111 
Week 112 348 0,498 
Week 114 367 0,525 
Week 122 639 0,914 
Week 130 688 0,984 
Week 146 698 0,998 
Table 9: Lost to follow-up in absolute number and percentage at selected 
measurement occasions 
The inspection of individual and mean weights per experimental group and age 
of the dams at pregnancy showed some important features that are to be 
considered in the following analysis:  
                                                          
8The “time” variable will be centered in the analysis, so that it will not represent the weeks of age 
but the weeks since the beginning of observation and treatment. The equivalence between these 
two measures is extremely straightforward (ctime= time-8). 
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• observations for all animals are present only for the first occasions, then they 
start to experience mortality; by week 114, when rats are in their elderly age 
(and measurements of body weight start being performed every 8 weeks) half 
of the original population remains; since later assessments happens more 
sporadically, they involve fewer and fewer subjects, as from table 3; 
 
Figure 12: Average weight for females and males by treatment and age of dams at 
start of gestation 
• as expected, males are heavier than females, the treatment proportionally 
affects body weight, and the age of dams at pregnancy doesn’t seem relevant 
for rats from the control groups, while it corresponds to sensibly different 
paths for the treated;  
• the weights sharply increase during the first weeks of observation, until 
around the age of 13 weeks, then the growth stops or continue at a slower pace 
once the adult size is reached; 
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Figure 13: Growth trajectory of body weights from a random sample of II 
generation rats. 
• variability is very important, both within subjects, and among them. Most 
growth lines present indeed a lot of erraticism that is usually attributable to 
small variations in the health status of the subjects, that are not relevant but, 
since the measurements are very frequent, are registered. All trends, 
nevertheless, are quite similar in shape during the first period of growth, while 
during the adult/elderly period peculiar patterns appear: very often, weights 
decrease in the very last part of life, because of diseases, or the physiologic 
ageing process. Some animals, in contrary, experience an extreme (in 
magnitude and velocity) increase of weight that is likely due to the presence of 
neoplastic masses. 
The conclusions that can be drown from this exploration of data is that models 
will probably suffer from this pronounced variability, that it is important to 
consider all the variables that characterize the data (sex, treatment and the age of 
dams at gestation), and that linear models can’t be directly fitted to data, so 
several expedients will be applied, and their use and suitability evaluated. These 
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can be resumed in (I) mathematically manipulating variables so that the linear 
assumption appears reasonable, (II) using polynomial functions to represent time, 
so that a non-linear trend can be modelled using a linear function and, finally, (III) 
fitting nonlinear “human” growth models. Furthermore, since the observations in 
the last occasions of measurement are drastically reduced and represent very old 
rats, that likely experience weight variations according to their health status more 
than to the treatment regime, the observations registered after week 114 will not 
be considered.  
The first step to analyse body weight was fitting linear mixed effects models; 
to do so, some mathematical manipulation of data was necessary, so that the 
assumption of linearity remained reasonable; after several tries9,the log-
transformation of the time variable was chosen.  
It was chosen to compare the estimates and performance of two models that 
could be justifiable and meaningful for these data: one only allows for random 
intercept and slopes for each litter, since, at least in the first part of life, the 
weights of each pup within the same litter tend to be quite similar, but the 
differences among litters can be remarkable; they tend to level-up with time, but a 
great variability at individual level remains. The alternative possibility was to 
include a random intercept only at the litter level, and to include the subject level 
in the analysis, allowing every subject within each litter to have its own random 
intercept and slope. Information criteria and likelihood-ratio tests favoured this 
last option, since such a setting would probably help explaining the peculiar 
growth paths in adult/elderly life we highlighted before, refining the fit of the 
models and reducing the unexplained variability; on the other hand, it probably 
unnecessary weights the model down. 
Fixed effects were assessed in a very straightforward way, since they consist of 
experimental conditions: the relevance of sex, treatment received, and the age of 
the dams at the beginning of gestation was evaluated, and the first two were found 
to have a relevant influence on body weights. Variables and model selection were 
performed according to statistical significance of the estimates, to the results of 
                                                          
9Weight raised at the power of 2, 2.5, 3, 3.5, 4; natural logarithm of time, time1/2, 1/time, 1/time2. 
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likelihood ratio tests in case of nested models, or considering information criteria 
as AIC and BIC, and, as usual, pairing all this with the knowledge of the 
phenomenon under study and biological meaning. The last consideration regards 
the fact that this type of repeated measurements can’t be independent between 
subsequent assessments, but each value highly depends on the previous ones, with 
correlation decreasing the more the observations become far apart in time. To 
account for this, the possibility of shaping the structure of the residual errors at the 
individual level was evaluated. The variance-covariance structure was built to 
have serially correlated residuals using an exponential specification, where 
𝑐𝑜𝑣(𝜀𝑖𝑡, 𝜀𝑖𝑡′) =  𝜎𝜀 
2 𝑒𝑥𝑝{−𝛾(𝑡′ − 𝑡)} 
which tends to the variance the closer are the measurements, and exponentially 
decreases to zero as they become more distant in time.  
Observations 36,606 Model 1  Model 2 
Number of groups 98 Coef s.e. Coef s.e. 
Fixed part 
 
 
 
 Time (ln(centered 
time)) 
 
77.688*** (1.980) 76.405*** (0.914) 
Treatment 
 
12.170** (5.290) 17.858*** (4.837) 
Sex 
 
158.158*** (0.543) 66.573*** (3.144) 
Constant 
 
67.011*** (4.513) 100.786*** (3.810) 
      Random part 
    Litter: Unstructured (1) sd(logct) 19.401 (1.430) 
             Identity (2)  sd(_cons) 35.886 (3.193) 17.480 (2.325) 
 
corr(logct,_cons) -.707 (.061) 
  Subject: Independent 
(2) sd(logct) 
  
18.329 (.782) 
 
sd(_cons) 
  
1.49e-07 . 
Residual: Exponential 
(2) 
rho(e) 
  
.395 (.015) 
 
sd(Residual) 47.552 (.176) 51.360 ( 1.007) 
Goodness of fit 
    Log restricted-
likelihood 
 
-193723.6 -155124.1 
AIC 
 
387463.1 310264.3 
BIC 
 
387531.2 310332.4 
*** p<0.01, ** p<0.05, 
* p<0.1 
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Table 10: Multilevel mixed effects models using transformed variables; results of 
regression of weight on ln(time, centered) and experimental variables. 
The models give quite similar results in terms of significance and type of effect of 
each variable. If we consider only random differences at the litter level, we find 
out that female rats weight approximately 70 g at their first assessment at 8 weeks 
of age while males are sensibly heavier, of around 160 g; treatment is responsible 
of a smaller, but still relevant, increase in weight, of around 12 g. The 
physiological growth that all animals experience in time is around 77 g for 
females of the control group, per unit of time (which is on logarithmic scale). 
The graphical representation of the fixed effects in figure 4 and6, and of the fixed 
and random effects for some selected litters in figure 5may help clarify these 
findings.  
 
Figure 14: Plot of data and estimated fixed effects, model 1 
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Figure 15: Data and linear prediction with fixed and random portion in four 
selected litters, model 1. 
 
Figure 16: Plot of data and estimated fixed effects, model 2. 
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Figure 17: Data and linear prediction with fixed and random portion in four 
selected litters, model 2. 
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Residuals were analysed to verify whether the underlying basic assumptions 
(linearity of the relationship between the outcome and the regressors, normality 
and homoscedasticity of residuals) were met, and they highlighted several 
problems.  
 
 
Figure 18: Evaluation of linearity: comparison between growth trajectory and 
linear regression in three random samples 
As it was clear from the beginning, linearity is hardly respected even when a 
transformation of the variables is used: the main problem clearly arises in the 
relation between growth of body weights and time, since even if a linear trend can 
approximate reasonably well the growth in the first period of life, the 
unpredictable variability in the last phase is often too high. 
The representation of normal probability plots and standardized residuals 
estimated for each level of the models shows more issues that can probably be 
attributed, again, to the extreme variability of body weights among rats: too many 
observations present extreme values both in the upper and in the lower tail of the 
distribution.  
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Figure 19: Evaluation of normality and homoscedasticity of residuals using 
Normal probability plots and standardized residuals. 
Even the assumption of homoscedasticity raises some doubts: coherently with 
what was highlighted so far, body weights can grow to quite extreme values, or 
fall sharply in relatively short time, mostly in adult and aged rats. The fact that 
standardized residuals tend to increase with time is therefore not so surprising.  
These analyses show that indeed linear mixed effect models are a powerful tool to 
represent the multilevel nature of data, to account for the fact that they are 
repeated measurements of the same physical trait, and to handle the lack of 
randomization of this particular dataset, too. The great variability in the possible 
growth paths and its non-linear trend in time doesn’t allow, nevertheless, to 
consider those illustrated above as the optimal models for this type of analysis, 
and to take the estimates as definitive. Given these drawbacks, a different 
approach was tried: the same models were fitted using polynomial terms to 
represent time, so that the trajectory of growth could be better represented.  
The models were built considering again sex, experimental treatment and age 
of each dams at the beginning of gestation as covariates to include in the structural 
part; it was chosen to include a random effect depending on the variable “time” at 
the familiar level.  
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Observations 36,606 Quadratic Cubic  
Number of groups 98 Coeff s.e. Coeff s.e. 
Fixed Part . 
 
. 
 Time 
 
6.906*** (0.178) 11.871*** (0.266) 
Time 2 
 
-0.048*** (0.002) -0.174*** (0.006) 
Time 3    .0008*** (.00003) 
Treatment 
 
9.039* (5.224) 11.270** (5.221) 
Sex 
 
158.225*** (0.613) 158.184*** (0.569) 
Constant 
 
162.674*** (3.790) 124.929*** (3.975) 
Random Part 
    Litter: 
Unstructured  sd(ctime) 1.715 '(.102) 2.456 . 
 
sd(ctime2) .015 (.001) .049 . 
 
sd(ctime3) 
  
.0003 . 
 
sd(_cons) 27.184 (2.188) 29.202 . 
 
corr(ctime,ctime2) -.901 . -.883 . 
 
corr(ctime,ctime3) 
  
.752 . 
 
corr(ctime,_cons) -.209 . -.401 . 
 
corr(ctime2,ctime3) 
  
-.962 . 
 
corr(ctime2,_cons) .342 (.023) .438 . 
 
corr(ctime3,_cons) 
  
-.368 . 
 
sd(Residual) 53.517 (.198) 49.662 . 
Goodness of Fit 
    
Log restricted likelihood  -198178.5 -195553.3 
AIC 396377 391118.7 
BIC 
 
396462.1 391169.7 
*** p<0.01, ** p<0.05, * p<0.1 
Table 11 : Multilevel mixed effects models using polynomial terms; results of 
regression of body weights on second and third degrees polynomial terms for time 
and experimental variables 
Quadratic and cubic models were evaluated adding the second and the third 
power of variable “time” in the model equation, and the cubic was found to be the 
better for these data. The results are not so dissimilar to those obtained before, 
most of the differences among body weights can be explained by sex, but the 
consumption of Coca Cola ad libitum is a relevant factor, as well.  
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Figure 20: Plot of data and estimated average predictors, cubic model. 
Differences among litters are relevant, too, so it’s worthy adding random 
effects at this level.  
 
Figure 21: Data and linear prediction with fixed and random effects in four 
selected litters, cubic model. 
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The display of residuals highlights that the problems arising from the extremes 
behaviour of weights of elderly or ill rats remains quite evident: residuals can’t 
really be said to distribute normally, and appear quite heteroscedastic in relation 
to time, too, as can be seen in figures 12.  
 
Figure 22: Evaluation of the assumption of normality and homoscedasticity of 
residuals, cubic model. 
Polynomial terms have proven to be a worthy expedient to be able to model curve 
trajectories remaining in the framework of linear mixed effects models, but the 
noisy nature of data continues to create issues that this model can hardly handle 
and that may prevent to consider the results reliable.  
A third option was attempted, just in an explorative way: a generalized additive 
mixed effect model was fitted, where time was not included directly, but trough a 
smoothed function. It was then added to the other regressors, always keeping a 
multilevel structure with random effects at litter level. This attempt proved quite 
effective in taking into account time and model its irregular trend in quite a simple 
way. It may be proficiently used to explore data, and eventually to model them, 
but the thorough evaluation of this method is left for the next future. 
In this occasion it was chosen to explore more in depth the models for human 
growth, and to try to apply them to animal growth. The choice of which to use 
was based on the possibility to adapt them to the available data in a relatively easy 
way, that means that the models had not to be too strictly bonded to 
characteristics, rhythms and timings typical of human growth only. It was indeed 
showed (Sengupta 2013) that rat and human life are correlated, taking the whole 
life span into account, so that one human year equals 13.2 rat days; it is better, 
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nevertheless, to consider different phases separately, since while humans develop 
very slowly, rats have a very accelerated pace, and reach sexual maturity around 6 
weeks of age: according to this equivalence, the rats that we are observing could 
be considered adolescents, but as becomes clear from Table 5, it is impossible to 
draw an exact and constant equivalence between rats’ age and humans’ age.  
Period Correspondence to 1 human year 
Entire life span 13.2 rat days 
Weaning period 42.4 rat days 
Pre-pubertal period 3.3 rat days 
Adolescent period 10.5 rat days 
Adulthood 11.8 rat days 
Aged phase 17.1 rat days 
Average 16.4 rat days 
 
Table 12: Correspondence of one human year with rat days at different phases of 
life, from Sengupta (2013) 
This is the reason behind the choice of not considering those parametric, 
nonlinear models that were designed to account for the specific features and 
mechanisms of human growth, but to focus on those that could be used to describe 
a path, similar for intensity and velocity to that of humans during young age. 
Some of the models that might answer to these needs are the Jenns and Bayley, 
the Count and the 1st order Berkey and Reed model, that are usually employed to 
analyse growth during adolescence, and are therefore built to describe a steep 
growth during the first part of the curve, that slows down at the reaching of the 
approximate adult size. They were fitted to data to verify which could be the best, 
and the choice fell on the Berkey and Reed model, basing the decision on the 
graphical examination of the curves and on the comparison of the measures of 
goodness of fit. The model uses four parameters to describe the specific functional 
form of the individual growth curve 
1𝑠𝑡  𝑜𝑟𝑑𝑒𝑟:  𝑦 = 𝑎 + 𝑏 𝑡 + 𝑐 ln(𝑡 + 1) +
𝑑
𝑡
 
that may represent the starting point, growth rate, acceleration and deceleration of 
growth, so that the trajectory is allowed to be curvilinear and to have one or more 
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inflection points. Here, the function was built so that each of the parameters 
would be dependent on age10, sex and treatment received; a random effect at the 
litter level was introduced and evaluated for all of them, so that each litter is not 
constrained to have the same intercept, or, for example inflection point.  
  
Coef. Std. Err. z P>|z| [95% Conf. Interval] 
a sex 565.789 (33.214) 17.035 (0.000) 500.691 - 630.887 
 
treat -380.528 (33.304) -11.426 (0.000) -445.803 - -315.252 
 
_cons 655.279 (28.321) 23.137 (0.000) 599.770 - 710.788 
b sex -0.150 (0.122) -1.224 (0.221) -0.390 - 0.090 
 
treat -0.846 (0.196) -4.310 (0.000) -1.230 - -0.461 
 
_cons 1.567 (0.147) 10.639 (0.000) 1.279 - 1.856 
c sex 78.149 (9.415) 8.301 (0.000) 59.696 - 96.601 
 
treat -118.262 (9.444) -12.522 (0.000) -136.773 - -99.751 
 
_cons 89.059 (8.016) 11.110 (0.000) 73.347 - 104.770 
d sex -3,381.295 (137.819) -24.534 (0.000) -3,651.416 - -3,111.175 
 
treat 1,330.012 (138.127) 9.629 (0.000) 1,059.288 - 1,600.736 
 
_cons -3,125.875 (117.836) -26.527 (0.000) -3,356.830 - - 2,894.921 
       
Litter: Identity var(U0) '.567 '.081 
  
.427 - .752 
var(Residual) 
 
1966.77 14.557 
  
1938.44 – 1995.51 
 
Figure 23: Estimates from Berkey- Reed model, offspring 
The estimated parameters are not easy to interpret; what is relevant is that the 
treatment is responsible for significant differences in all parameters. This becomes 
very clear if we represent the curves graphically: the plot for some randomly 
selected litters shows that the model fits most of the growth trajectories quite 
good, while the average curves for treated and controls, separated by sex, show 
that both these covariates affect sensibly body weights.  
                                                          
10 This time was considered without centering or transformation, since this model requires time to 
be expressed as “age”.  
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Figure 24:Plot of data and estimated average predictions, Berkey-Reed growth 
model 
 
 
Figure 25: Plot of data and linear predictions with fixed and random part in four 
randomly selected litters, Berkey-Reed growth model 
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The examination of residuals points out the same problems that emerged with 
all other analysis: the residuals can hardly be considered to respect all the 
assumptions that underlie the model.   
 
Figure 26: Evaluation of the assumptions of normality and homoscedasticity of 
the model using residuals. 
At this point it is useful to draw some conclusions: these data have some very 
peculiar characteristics, the most relevant for their analysis are non-linearity and 
the fact that they can take unexpected, extreme turns upwards or downwards, 
mostly when rats are close to the end of life, reflecting the presence of important 
neoplastic masses or a worsening of the health conditions. These features should 
discourage the use of methods based on the comparison of measures of synthesis 
like the group means, because they could be heavily affected by the atypical 
recordings, giving an unrealistic picture of the situation and possibly preventing to 
detect differences caused by experimental factors.  
The use of multilevel mixed effects models is surely to be encouraged, since it 
allows to analyse directly the recording of each subject, without concerning about 
the differences in the duration of the recordings. They are also a precious tool in 
case of clustered data, and in this rather peculiar experimental design, when no 
randomization was performed on a whole cohort of rats. The most straightforward 
specifications of such models using a proper linear function is not the best option, 
because it requires a transformation of the variables, so that the advantage of a 
simple functional forms is counterbalanced by the difficult interpretation of 
transformed variables. Even the introduction of polynomial terms, that allow to 
represent a curve trajectory remaining in the frame of a linear function, slightly 
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reduces the ease of the interpretation, but it can still be acceptable if it allows a 
more faithful representation of the growth trajectories; as their plot showed, 
nevertheless, it’s not always the case. The methods that we feel to choose as 
preferred are the nonlinear growth models that were “borrowed” from human 
studies: a wide variety exists, so one can select the most appropriate every time, 
according to the characteristics of data. In this case, too, the model parameters are 
not easy to interpret, but a clear indication is provided about the statistical 
significance of each covariate and its ability to affect the outcome.  
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Chapter 5 Conclusions 
 
 
The research centre that asked for this collaboration, that concretized in this 
research, is active since decades in testing the carcinogenic potential of substances 
and compounds that the population is frequently exposed to, for occupational or 
lifestyle reasons, and was in several occasions the first to outline the health risks 
connected to chemicals that are today recognized as human carcinogens (see (S. 
C. Maltoni C. 1979) and (C. B. Maltoni C. 1983) for the example of benzene, or 
(Belpoggi F 1995) for Methyl-tert-Butyl Ether). Nevertheless, in some occasions, 
the results obtained from its experiments failed to be recognized by the regulatory 
organs in charge because they were not sufficiently strong and universally 
accepted from a methodological point of view, rather than because of a weak 
scientific evidence.  
Deepening the knowledge and understanding of the methods used for the 
statistical analysis of their results is one of the strategies to enhance the quality of 
the research, and it is the ground on which a strong scientific base can be built. 
This work is an attempt in this direction: it aims to go beyond the techniques that 
are performed routinely, to explore the characteristics of the data and to try to 
understand the mechanisms that determined them, and, in this framework, to 
propose some methodologies that manage to answer the research questions in a 
more comprehensive way.  
The data were chosen among those that were published long before, did not 
contain any sensitive or reserved information and resented some features that 
72 
 
made them particularly challenging for the researchers to analyse. The choice fell 
on the Coca- Cola study, a series of 4 experiments that started in the late ‘80s and 
whose results were not found to be particularly controversial or worrying, and 
were indeed published only in 2006. They presented the particularity of involving 
two generations of subjects, the first randomized, the second included in blocks 
into the experiment, to evaluate the effect of exposing pups in a particular window 
of susceptibility, the perinatal period. They were also one of the few cases where 
the exposure determined an important increase in body weight, so that this 
measure needed to be considered with more attention than usual.  
This work focused on two topics that are not the main focus of the interest in 
carcinogenicity studies, but deserve a thorough analysis for the reasons that were 
illustrated at the beginning of each of the two chapters dedicated to data analysis.  
For the analysis of survival, the time-to-death of each individual was 
examined, to evaluate the effect of the experimental regime received; two separate 
analyses were performed, one involving breeders, the other offspring only, 
because we assume the former observations to be independent, while the latter are 
taken on siblings, so independence can’t be assumed. The effect of the exposure 
was evaluated, while it was necessary to control for the influence of other likely 
risk factors: this was possible thanks to the modelling approach. Proportional 
hazard models were fitted, and the Accelerated failure-time model, parametrized 
using a generalized gamma distribution, was used when the assumption of PH 
didn’t hold. The use of frailties was evaluated: a univariate term was introduced 
for the breeders, at the individual level, to control for possible unobserved 
heterogeneity; a shared frailty was used to account for the lack of independence 
among subjects from the second generation, that contained many siblings. The 
results say that the treatment appears relevant in accelerating death among the 
individuals exposed from adult life; the frailty could not be introduced in the best-
fitting model because of computational problems, so its influence remains to be 
verified. The models estimated for the rats of second generation initially 
confirmed the role of the treatment in increasing the risk of death, but when a term 
for a common, unobserved source of heterogeneity was introduced to consider the 
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effect of familiarity among members of the same litters, it became the only 
relevant variable.  
These findings underline some very important principles: the first is the 
importance of properly choosing the methods and specifying the models, where 
properly means in a data-and-experience-driven way. A thorough knowledge of 
the data and of the dynamics that contribute to determine them is always a good 
starting point to build plausible, really representative and meaningful models. 
Another crucial point is the fact that model checking and verification of the 
respect of the assumptions that lie at the foundations of any method should 
become a routine embedded in every analysis, while it remains not yet so common 
(or, at least, not always explicitly reported) in the literature regarding 
carcinogenicity bioassays.  
The methods for the analysis of time-to-event are really flexible: here they 
were use for the most “literal” application, to evaluate the general survival of the 
population under study. They would be suitable for several other applications, if 
the collection of additional information was possible: it would be interesting for 
example to build a classification of tumours based on their lethality or 
incidentality; being able to attribute a cause of death to each animal, or to register 
the time of onset for those (rare) type of lesions that are detectable while the 
animals are still alive. The collection of such additional information would greatly 
enhance the possibilities for analysis, making possible to consider cause-specific 
mortality or methods to handle competing risks. Another interesting possibility 
that can immediately be evaluated and implemented with the information 
available so far is the joint modelling of longitudinal measures (such as body 
weights) with survival data.  
The second part of this work was dedicated to the analysis of the longitudinal 
measurements of body weights from the group of rats of second generation. The 
main purpose was to find the best modelling approach to adequately describe the 
process of growth of these animals, from their youth to the reaching of the adult 
size; once this is assessed, the influence of the exposure to Coca-Cola and the 
effect of other covariates has been also evaluated.  
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The data consisted of weekly recordings of body weights of young rats, 
followed from the age of 8 weeks until spontaneous death: the observations are 
very numerous and were collected regularly; they present a high variability among 
individuals that is at least partially expected, because males and females can have 
very different sizes, and sometimes a very high variability within individuals as 
well, that is due to quite extreme weight increases or decreases due to health 
issues or mortality.  
All analyses were made in the framework of mixed- effects models, because 
they are the best approach to treat longitudinal data and allow to include 
additional level of grouping, that in this case consists of litters. It is therefore 
possible to account for the structural effect of covariates, that we expect to act the 
same way on all individuals, and to add random effects that introduce a 
correlation among the subjects within the same group (here: within the pups of the 
same litter.  
Mixed effects can be included in a variety of models: here several were 
explored, and their suitability has been evaluated. The first was a linear 
formulation, which is reasonable only if variables undergo a transformation to 
linearize the trend of body weights, that increase very rapidly in the first period 
and gradually slow down. The log-transformation of the time variable was used. 
The second was to build a linear function with polynomial terms for time, to allow 
the trajectory to assume a curve trend; the cubic function of time, that allows for 
two inflections points, was found to be the best option. Finally, growth models 
were fitted: they are non-linear models that were specifically created to study 
human development. We selected those that could easily be adapted to the animal 
context, since they were less sophisticated to catch characteristics specific of 
human and infant growth.  The Berkey and Reed model proved the best for this 
purpose.  
Even if it's not possible to directly compare the results of these models using 
the measures of information criteria, we can still draw some conclusions. Growth 
models represent an interesting way to analyse the body weights of young rats, 
since not only they allow to evaluate the differences among experimental groups, 
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but also give information about the growth process. Choosing the appropriate 
formulation for the data allows to represent quite precisely the shape of the 
trajectories; they may become useful in those studies where the development and 
sexual maturation of the animals are investigated, because they can be used to 
obtain an estimate of the start and development of the adolescent period.  
They were not explicitly considered here, but these analyses of course are 
suitable for adult rats as well; for this purpose, a linear model or a quadratic 
polynomial of time should be the best options, because rarely growth models are 
built to model the weight trajectories during the whole lifespan of individuals, so a 
simpler and more efficient alternative is to be preferred.  
Some issues remain open, like the problem of how to consider and treat the 
extreme trends that some individual experience in the last part of their life; it is an 
interesting feature, that is usually associated with the worsening of the health 
conditions, but it can also affect heavily the estimates and the overall likelihood of 
the models. It could be useful to this regard to further study and develop the 
application of general additive mixed models to these data, that were only briefly 
explored during this analysis but seemed quite promising. Allowing to include a 
nonparametric, smoothed function of time in the classic linear regression function, 
this approach can handle variables with an irregular trend like these body weights, 
and at the same time maintain a simple and understandable interpretation for the 
experimental variables.  
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Appendix 1: Analysis of residuals for survival analysis 
1.1 Cox Proportional Hazard model, breeders 
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Test of proportional-hazards assumption 
 
      Time:  Time 
      ----------------------------------------------------------------                           
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.05423         3.84        1         0.0499 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.02560         0.85        1         0.3570 
      ------------+--------------------------------------------------- 
      global test |                      4.78        2         0.0915 
      ---------------------------------------------------------------- 
 
 
      Time:  Log(t) 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.05282         3.65        1         0.0562 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.02284         0.68        1         0.4113 
      ------------+--------------------------------------------------- 
      global test |                      4.40        2         0.1107 
      ---------------------------------------------------------------- 
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      Time:  Kaplan-Meier 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.05994         4.70        1         0.0302 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.03101         1.24        1         0.2645 
      ------------+--------------------------------------------------- 
      global test |                      6.06        2         0.0483 
      ---------------------------------------------------------------- 
 
 
 
1.2 Accelerated failure-time model, generalized Gamma distribution, breeder 
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1.3 Cox Proportional Hazard model, offspring 
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Test of proportional-hazards assumption 
 
      Time:  Time 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.05304         2.01        1         0.1568 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.00458         0.01        1         0.9029 
      30b.momstart|            .            .        1             . 
      39.momstart |     -0.07824         4.30        1         0.0382 
      55.momstart |     -0.07424         3.86        1         0.0494 
      ------------+--------------------------------------------------- 
      global test |                      7.81        4         0.0986 
      ---------------------------------------------------------------- 
 
 
      Time:  Kaplan-Meier 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.03200         0.73        1         0.3928 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.02653         0.50        1         0.4796 
      30b.momstart|            .            .        1             . 
      39.momstart |     -0.07956         4.44        1         0.0350 
      55.momstart |     -0.05326         1.99        1         0.1585 
      ------------+--------------------------------------------------- 
      global test |                      6.25        4         0.1815 
      ---------------------------------------------------------------- 
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      Time:  Rank(t) 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.03189         0.72        1         0.3945 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.02669         0.51        1         0.4769 
      30b.momstart|            .            .        1             . 
      39.momstart |     -0.07962         4.45        1         0.0349 
      55.momstart |     -0.05328         1.99        1         0.1584 
      ------------+--------------------------------------------------- 
      global test |                      6.25        4         0.1809 
      ---------------------------------------------------------------- 
 
 
 
 
 
 
 
 
1.4 Cox Proportional Hazard model with shared Gamma frailty, offspring 
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    Test of proportional-hazards assumption 
 
      Time:  Time 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.04712         1.78        1         0.1826 
      0b.treat    |            .            .        1             . 
      1.treat     |      0.00100         0.00        1         0.9659 
      30b.momstart|            .            .        1             . 
      39.momstart |     -0.03689         2.48        1         0.1151 
      55.momstart |     -0.04387         3.17        1         0.0752 
      ------------+--------------------------------------------------- 
      global test |                      5.85        4         0.2108 
      ---------------------------------------------------------------- 
 
 
      Time:  Kaplan-Meier 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.02686         0.58        1         0.4474 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.01614         0.48        1         0.4887 
      30b.momstart|            .            .        1             . 
      39.momstart |     -0.03295         1.98        1         0.1593 
      55.momstart |     -0.02387         0.94        1         0.3329 
      ------------+--------------------------------------------------- 
      global test |                      3.64        4         0.4572 
      ---------------------------------------------------------------- 
 
 
      Time:  Rank(t) 
      ---------------------------------------------------------------- 
                  |       rho            chi2       df       Prob>chi2 
      ------------+--------------------------------------------------- 
      0b.sex      |            .            .        1             . 
      1.sex       |     -0.02673         0.57        1         0.4495 
      0b.treat    |            .            .        1             . 
      1.treat     |     -0.01628         0.49        1         0.4850 
      30b.momstart|            .            .        1             . 
      39.momstart |     -0.03300         1.99        1         0.1587 
      55.momstart |     -0.02392         0.94        1         0.3320 
      ------------+--------------------------------------------------- 
      global test |                      3.65        4         0.4551 
      ---------------------------------------------------------------- 
